<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="mco2454" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">MedComm (2020)</journal-id><journal-id journal-id-type="iso-abbrev">MedComm (2020)</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2688-2663</journal-id><journal-id journal-id-type="publisher-id">MCO2</journal-id><journal-title-group><journal-title>MedComm</journal-title></journal-title-group><issn pub-type="epub">2688-2663</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38124785</article-id><article-id pub-id-type="pmc">PMC10732331</article-id><article-id pub-id-type="doi">10.1002/mco2.454</article-id><article-id pub-id-type="publisher-id">MCO2454</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Reviews</subject></subj-group></article-categories><title-group><article-title>Mechanisms and therapeutic strategies of extracellular vesicles in cardiovascular diseases</article-title><alt-title alt-title-type="left-running-head">LI <sc>et&#x000a0;al</sc>.</alt-title></title-group><contrib-group><contrib id="mco2454-cr-0001" contrib-type="author"><name><surname>Li</surname><given-names>Qirong</given-names></name><xref rid="mco2454-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mco2454-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mco2454-cr-0002" contrib-type="author"><name><surname>Feng</surname><given-names>Qiang</given-names></name><xref rid="mco2454-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mco2454-cr-0003" contrib-type="author"><name><surname>Zhou</surname><given-names>Hengzong</given-names></name><xref rid="mco2454-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mco2454-cr-0004" contrib-type="author"><name><surname>Lin</surname><given-names>Chao</given-names></name><xref rid="mco2454-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="mco2454-cr-0005" contrib-type="author"><name><surname>Sun</surname><given-names>Xiaoming</given-names></name><xref rid="mco2454-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="mco2454-cr-0006" contrib-type="author"><name><surname>Ma</surname><given-names>Chaoyang</given-names></name><xref rid="mco2454-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="mco2454-cr-0007" contrib-type="author"><name><surname>Sun</surname><given-names>Liqun</given-names></name><xref rid="mco2454-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="mco2454-cr-0008" contrib-type="author" corresp="yes"><name><surname>Guo</surname><given-names>Gongliang</given-names></name><xref rid="mco2454-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>docg@jlu.edu.cn</email></address></contrib><contrib id="mco2454-cr-0009" contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Dongxu</given-names></name><xref rid="mco2454-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>wang_dong_xu@jlu.edu.cn</email></address></contrib></contrib-group><aff id="mco2454-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Cardiology</named-content>
<institution>China&#x02010;Japan Union Hospital of Jilin University</institution>
<city>Changchun</city>
<country country="CN">China</country>
</aff><aff id="mco2454-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Laboratory Animal Center</named-content>
<institution>College of Animal Science</institution>
<institution>Jilin University</institution>
<city>Changchun</city>
<country country="CN">China</country>
</aff><aff id="mco2454-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">School of Grain Science and Technology</named-content>
<institution>Jilin Business and Technology College</institution>
<city>Changchun</city>
<country country="CN">China</country>
</aff><aff id="mco2454-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>Hepatology Hospital of Jilin Province</institution>
<city>Changchun</city>
<country country="CN">China</country>
</aff><aff id="mco2454-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Pathogenobiology</named-content>
<institution>Jilin University Mycology Research Center</institution>
<institution>College of Basic Medical Sciences</institution>
<institution>Jilin University</institution>
<city>Changchun</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Gongliang Guo, Department of Cardiology, China&#x02010;Japan Union Hospital of Jilin University, Changchun, China.<break/> Email: <email>docg@jlu.edu.cn</email>
<break/>Dongxu Wang, Laboratory Animal Center, College of Animal Science, Jilin University, Changchun, China.<break/> Email: <email>wang_dong_xu@jlu.edu.cn</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2023</year></pub-date><volume>4</volume><issue seq="540">6</issue><issue-id pub-id-type="doi">10.1002/mco2.v4.6</issue-id><elocation-id>e454</elocation-id><history>
<date date-type="rev-recd"><day>15</day><month>11</month><year>2023</year></date>
<date date-type="received"><day>18</day><month>5</month><year>2023</year></date>
<date date-type="accepted"><day>16</day><month>11</month><year>2023</year></date>
</history><permissions><!--&#x000a9; 2023 MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2023 The Authors. <italic toggle="yes">MedComm</italic> published by Sichuan International Medical Exchange &#x00026; Promotion Association (SCIMEA) and John Wiley &#x00026; Sons Australia, Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:MCO2-4-e454.pdf"/><abstract><title>Abstract</title><p>Cardiovascular disease (CVD) significantly impacts global society since it is the leading cause of death and disability worldwide, and extracellular vesicle (EV)&#x02010;based therapies have been extensively investigated. EV delivery is involved in mediating the progression of CVDs and has great potential to be biomarker and therapeutic molecular carrier. Besides, EVs from stem cells and cardiac cells can effectively protect the heart from various pathologic conditions, and then serve as an alternative treatment for CVDs. Moreover, the research of using EVs as delivery carriers of therapeutic molecules, membrane engineering modification of EVs, or combining EVs with biomaterials further improves the application potential of EVs in clinical treatment. However, currently there are only a few articles summarizing the application of EVs in CVDs. This review provides an overview of the role of EVs in the pathogenesis and diagnosis of CVDs. It also focuses on how EVs promote the repair of myocardial injury and therapeutic methods of CVDs. In conclusion, it is of great significance to review the research on the application of EVs in the treatment of CVDs, which lays a foundation for further exploration of the role of EVs, and clarifies the prospect of EVs in the treatment of myocardial injury.</p></abstract><abstract id="mco2454-abs-0001" abstract-type="graphical"><p>Extracellular vesicles (EVs) have many potential applications in the study of cardiovascular pathophysiology. This article reviews the role of EVs in the pathogenesis and diagnosis of cardiovascular diseases (CVDs) in cardiovascular system. In addition, the mechanism and therapeutic methods of EVs promoting CVDs repair were summarized.
<boxed-text position="anchor" content-type="graphic"><graphic xlink:href="MCO2-4-e454-g005.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="mco2454-kwd-0001">cardiovascular disease</kwd><kwd id="mco2454-kwd-0002">exosomes</kwd><kwd id="mco2454-kwd-0003">extracellular vesicles</kwd><kwd id="mco2454-kwd-0004">myocardial injury</kwd><kwd id="mco2454-kwd-0005">stem cells</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>Jilin Province University Key Laboratory Scientific Research Program</funding-source><award-id>[2019]No.004</award-id></award-group><award-group id="funding-0002"><funding-source>Jilin Education Department Program</funding-source><award-id>JJKH20230259KJ</award-id></award-group><award-group id="funding-0003"><funding-source>Jilin Province Development and Reform Commission Program</funding-source><award-id>2023C028&#x02010;6</award-id></award-group><award-group id="funding-0004"><funding-source><institution-wrap><institution>Jilin Scientific and Technological Development Program
</institution><institution-id institution-id-type="doi">10.13039/501100013061</institution-id></institution-wrap></funding-source><award-id>20210101010JC</award-id><award-id>20210203080SF</award-id><award-id>20220505033ZP</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="2"/><page-count count="24"/><word-count count="15225"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>December 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.6 mode:remove_FC converted:20.12.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="mco2454-cit-0207">
<string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Mechanisms and therapeutic strategies of extracellular vesicles in cardiovascular diseases</article-title>. <source>MedComm</source>. <year>2023</year>;<volume>4</volume>:<elocation-id>e454</elocation-id>. <pub-id pub-id-type="doi">10.1002/mco2.454</pub-id>
</mixed-citation>
</p><fn-group><fn id="mco2454-note-0001" fn-type="equal"><p>Qirong Li, Qiang Feng, Hengzong Zhou, and Chao Lin contributed equally to this work.</p></fn></fn-group></notes></front><body><sec id="mco2454-sec-0010"><label>1</label><title>INTRODUCTION</title><p>The incidence and mortality of cardiovascular diseases (CVDs) remain high worldwide.<xref rid="mco2454-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> CVDs include atherosclerosis, ischemic heart disease, cerebrovascular disease, hemorrhagic stroke, hypertensive heart disease, cardiomyopathy, myocarditis, atrial fibrillation (AF), aortic aneurysm, peripheral vascular disease, and endocarditis.<xref rid="mco2454-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Mammalian cardiomyocytes have a limited capacity to proliferate after cardiac injury. Therefore, myocardial damage in CVDs is a major factor leading to adverse fibrosis and myocardial remodeling, contributing to the development of cardiac dysfunction and, ultimately, to heart failure (HF).<xref rid="mco2454-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> The pathogenesis of CVDs is complex due to many factors. Cardiac injury (including stress overload&#x02010;induced HF and ischemic injury) often leads to cardiac fibrosis, where a reparative fibrosis scar replaces heart tissue and gradually reshapes the tissue during myocardial cell death.<xref rid="mco2454-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> Several therapeutic interventions have been previously proposed, and cell&#x02010;based therapies are currently being intensively investigated.<xref rid="mco2454-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> However, the poor survival rate of transplanted cells in the ischemic heart tissue environment limits the clinical efficacy of cell therapy.<xref rid="mco2454-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> There is an urgent need to develop effective myocardial repair therapies and to clarify the detailed mechanisms of cardiac repair after CVDs.</p><p>Almost all known cell types secrete extracellular vesicles (EVs), which have the lipid bilayer structure.<xref rid="mco2454-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> EVs can be broadly classified into three types: apoptotic bodies, microvesicles, and exosomes.<xref rid="mco2454-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Exosomes are small membrane&#x02010;bound vesicles (30&#x02013;100&#x000a0;nm) that are produced during endosomal maturation into multivesicular bodies.<xref rid="mco2454-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Microvesicles are small vesicles (100&#x02013;1000&#x000a0;nm in diameter) that are shed from the cell membrane after cell activation, injury, or apoptosis. They originate from the cavitary membrane of polyvesicles and are released via the fusion of polyvesicles with the cell membrane. Under both normal and pathological conditions, EVs facilitate micro&#x02010;communication at the levels of cells, tissues, and organs by transporting proteins, mRNAs, and microRNAs (miRNAs/miRs).<xref rid="mco2454-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Further research has identified many functions for EVs, including involvement in immune responses, antigen presentation, tumor cell migration and proliferation, and regulation of apoptosis and autophagy.<xref rid="mco2454-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>
</p><p>Many studies have also shown that EVs play an emerging role in the context of CVDs.<xref rid="mco2454-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> The heart comprises diverse groups of cells, such as cardiomyocytes, fibroblasts, pericytes, smooth muscle cells, endothelial cells (ECs), and various immune cells,<xref rid="mco2454-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> which can play a role in repairing CVDs through cell&#x02010;to&#x02010;cell communication pathways such as the secretion of EVs. In addition, multiple studies have shown the potential involvement of circulating or endogenous stem cells in restoring myocardial tissue following irreversible injury.<xref rid="mco2454-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Cell&#x02010;free treatments based on EVs have attracted the interest of many researchers because they avoid the need to transplant large numbers of cells and are easier to apply. In addition, combining bioengineering methods with EVs to improve their delivery rate and stability in vivo is also an emerging research area in CVDs. Improving EV application through engineering methods may enhance their clinical potential in CVD applications.<xref rid="mco2454-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> In particular, hydrogels have been used as excellent carriers and can be used as cardiac patches or stents to achieve local delivery of therapeutic molecules and improve EV retention.<xref rid="mco2454-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
</p><p>This review summarizes the EVs that promote the pathogenesis of CVDs and can be used as diagnostic markers. The regulatory mechanism of EVs from different cardiac or stem cells promoting the repair of CVDs is also introduced. In addition, the therapeutic potential and bioengineering strategies of EVs in CVDs are further described. Moreover, it provides evidence for future clinical treatment of patients with CVDs. It also clarifies the therapeutic effect and potential molecular mechanism of CVDs treatment with EVs to a certain extent.</p></sec><sec id="mco2454-sec-0020"><label>2</label><title>EVs AND CVDs</title><p>EVs are nanoscale structures secreted by cells that contain various biomolecules involved in cellular communication and physiological processes.<xref rid="mco2454-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Increasing evidence confirms the important role of EVs as a tool for intercellular communication.<xref rid="mco2454-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> EVs have attracted considerable attention due to their unique properties, making them an ideal choice for diagnosis and treatment. EVs, including exosomes, are an early marker of CVDs and a key mediator of cardiac protection.<xref rid="mco2454-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> In addition, many studies have shown that non&#x02010;coding RNAs (ncRNAs) play an important role in CVDs. Moreover, EVs can be involved in pathogenesis by transferring relevant regulatory biomolecules, such as ncRNAs, to target cells to regulate their function and activate or silence genes<xref rid="mco2454-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> (Figure&#x000a0;<xref rid="mco2454-fig-0001" ref-type="fig">1</xref>).</p><fig position="float" fig-type="FIGURE" id="mco2454-fig-0001"><label>FIGURE 1</label><caption><p>Mechanisms of extracellular vesicles (EVs) in the pathogenesis of cardiovascular diseases (CVDs). EVs from inflammation&#x02010;related cells influence the progression of CVDs by inhibiting macrophage polarization, angiogenesis, and promoting inflammatory responses. EVs from cardiac&#x02010;related cells influence CVDs progression through regulation of mesenchymal stem cells (MSCs) and delivery of microRNAs (miRNAs) and circular RNAs (circRNAs). EVs from platelets and serum also play a role in promoting CVDs. The structure schematic diagram of EVs is in the upper left corner. EVs usually contain substances such as DNA, RNA, and proteins. The yellow arrow represents the process of promoting CVDs.</p></caption><graphic xlink:href="MCO2-4-e454-g004" position="anchor" id="jats-graphic-3"/></fig><sec id="mco2454-sec-0030"><label>2.1</label><title>The role of EVs in the pathogenesis of CVDs</title><p>Acute myocardial infarction (AMI) is a common manifestation of ischemic heart disease/coronary artery disease (CAD) with significant morbidity and mortality, posing a challenge worldwide.<xref rid="mco2454-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> Coronary reperfusion can lead to irreversible myocardial damage, known as myocardial ischemia/reperfusion (I/R) injury.<xref rid="mco2454-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Myocardial I/R&#x02010;induced myocardial cell damage, such as apoptosis and hypertrophy, can aggravate cardiac insufficiency and increase the incidence of poor prognosis. In addition, hypoxia&#x02013;reoxygenation (H/R) injury can cause various pathophysiological alterations in the myocardium, potentially resulting in the development of myocardial energy metabolism disorders and microvascular dysfunction.<xref rid="mco2454-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> H/R conditions are usually used to simulate I/R injury in myocardial cells.</p><p>Inflammation is a fundamental biological process that helps to maintain homeostasis, and the initial inflammatory response following a myocardial infarction (MI) is associated with the eventual size of the affected area.<xref rid="mco2454-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Macrophages are important effectors and regulators of the inflammatory cascade induced by MI. The polarization of macrophages during MI and I/R myocardial injury can be a potential therapeutic target.<xref rid="mco2454-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> I/R&#x02010;EVs aggravated I/R&#x02010;induced heart injury, promoted the M1&#x02010;like polarization of macrophages, and increased the expression of proinflammatory cytokines. In addition, other studies found that I/R&#x02010;EVs could deliver miR&#x02010;155&#x02010;5p to macrophages and activate the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 1 (STAT1) pathway, enhancing the inflammatory response and exacerbating local inflammation in the heart.<xref rid="mco2454-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> In addition, miR&#x02010;34a&#x02010;5p was identified as an exosome transferable molecule that induces cardiac aging&#x02010;related damage. The exosomes of macrophages treated with programmed cell death 1 (<italic toggle="yes">PDCD1</italic>/<italic toggle="yes">PD&#x02010;1</italic>) inhibitors can upregulate miR&#x02010;34a&#x02010;5p in cardiomyocytes and cause cardiac injury in mice. The results may provide new therapeutic targets for improving myocardial damage in cancer patients treated with PD&#x02010;1 inhibitors.<xref rid="mco2454-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> Moreover, studies have shown that M1&#x02010;like macrophages release many proinflammatory exosomes after MI, which have an anti&#x02010;angiogenic role and accelerate MI injury.<xref rid="mco2454-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> Additionally, miR&#x02010;155 in exosomes released by macrophages inhibits fibroblast proliferation, promotes inflammation at the cardiac injury site, and aggravates the adverse effects of myocardial injury.<xref rid="mco2454-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Neutrophils will rapidly accumulate in the ischemic area of the heart after MI and trigger the inflammatory response, form an extracellular trap, and produce EVs to exacerbate inflammation and heart damage.<xref rid="mco2454-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> Therefore, EVs containing inflammation&#x02010;related factors are involved in important pathways regulating CVDs.</p><p>Studies have shown that I/R significantly increases EV release by heart cells.<xref rid="mco2454-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> It has been shown that circular RNA (circRNA) levels in EVs isolated from mouse hearts were altered after I/R myocardial injury. The RNA sequencing of EVs identified 185 circRNAs whose levels differed significantly. circRNA&#x02013;miRNA analysis showed that these circRNAs could regulate target genes by regulating miRNAs, providing some potential targets and pathways involved in I/R injury.<xref rid="mco2454-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> Other studies have found that exosomes from damaged cardiomyocytes damaged and decreased the survival of transplanted bone marrow mesenchymal stem cells (BMSCs) for heart infarction, suggesting a new mechanism for cell survival after MI.<xref rid="mco2454-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> In addition, EVs induced by AMI impaired myocardial cell viability and worsened the extent of cardiac injury. miR&#x02010;503 is abundant in EVs during the early stages of AMI and plays a critical role in mediating myocardial injury. It induces mitochondrial metabolic dysfunction and myocardial cell death by interacting directly with peroxisome proliferator&#x02010;activated receptor &#x003b3;&#x02010;co&#x02010;activator 1&#x003b2; (<italic toggle="yes">PGC&#x02010;1&#x003b2;</italic>) and mitochondrial deacetylase sirtuin 3 (<italic toggle="yes">SIRT3</italic>).<xref rid="mco2454-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> Other studies have shown that miR&#x02010;155&#x02010;5p in serum&#x02010;derived exosomes can promote myocardial I/R injury by reducing peptidylprolyl isomerase F (PPIF/CypD) ubiquitination by neural precursor cell expressed, developmentally downregulated 4 (<italic toggle="yes">NEDD4</italic>).<xref rid="mco2454-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> In addition, erythrocyte and cardio&#x02010;derived exosomal hemoglobin might be associated with myocardial injury in patients with valvular heart disease, potentially contributing to acute cardiac damage in humans and animal models.<xref rid="mco2454-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>
</p><p>AF is a global epidemic with significant morbidity, mortality, and socio&#x02010;economic burden.<xref rid="mco2454-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> Studies have shown that EVs from the epicardial fat of AF patients are proinflammatory, profibrotic, and arrhythmogenic, thus promoting AF.<xref rid="mco2454-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> In addition, serum&#x02010;derived EVs containing long ncRNA (lncRNA) MIAT promote atrial fibrosis, inflammation, and oxidative stress by eliminating miR&#x02010;485&#x02010;5p&#x02010;mediated C&#x02013;X&#x02013;C motif ligand 10 (CXCL10) inhibition, and AF.<xref rid="mco2454-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> Atherosclerosis is a chronic inflammatory disease characterized by the formation of atherosclerotic plaques in the lining of the arteries and is a major cause of CAD, stroke, heart attack, and peripheral vascular disease.<xref rid="mco2454-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> EV&#x02010;derived miRNAs from atherogenic macrophages, in particular miR&#x02010;146a, may accelerate the development of atherosclerosis by reducing cell migration and promoting macrophage capture in blood vessel walls.<xref rid="mco2454-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref> Most cells involved in atherosclerosis release EVs, which can carry bioactive substances to downstream tissues through circulation. Studies have shown that EVs may transfer atherosclerosis to remote locations by carrying proinflammatory factors, specifically miR&#x02010;23a&#x02010;3p.<xref rid="mco2454-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> In addition, EVs released after monocyte/platelet activation may play a potential role in the development and progression of atherosclerosis, exhibiting proinflammatory effects.<xref rid="mco2454-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref>
</p><p>Therefore, inflammation&#x02010;related cells, including macrophages and neutrophils, mainly deliver miRNAs and inflammation&#x02010;related factors through EVs to promote inflammation of CVDs. In addition, cardiogenic EVs isolated from damaged myocardium or serum are mainly involved in the pathway of CVDs through the regulation of circRNAs and miRNAs.</p></sec><sec id="mco2454-sec-0040"><label>2.2</label><title>Potential role of EVs in diagnosing CVDs</title><p>Current methods for diagnosing CVDs are relatively expensive and fail to detect CVDs at an early stage. New biomarkers with diagnostic and risk assessment potential for CVDs are urgently needed (Table&#x000a0;<xref rid="mco2454-tbl-0001" ref-type="table">1</xref>). EVs are beneficial for liquid biopsies due to their ability to circulate in the body and their assessable contents.<xref rid="mco2454-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> Besides, levels of certain miRNA biomarkers extracted from EVs have been recognized as promising indicators for early CVD detection.<xref rid="mco2454-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref>
</p><table-wrap position="float" id="mco2454-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Extracellular vesicles (EVs) as an indicator in the diagnosis of myocardial injury is under preclinical study.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Disease</th><th align="left" rowspan="1" colspan="1">Source of EVs</th><th align="left" rowspan="1" colspan="1">EVs contents as markers</th><th align="left" rowspan="1" colspan="1">Effects</th><th align="left" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Myocardial ischemia/reperfusion injury</td><td align="left" rowspan="1" colspan="1">Ischemic myocardium</td><td align="left" rowspan="1" colspan="1">Cardiac and muscle&#x02010;specific microRNAs</td><td align="left" rowspan="1" colspan="1">As a specific early biomarker of heart injury</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Acute myocardial infarction</td><td align="left" rowspan="1" colspan="1">Urine and blood</td><td align="left" rowspan="1" colspan="1">The expression levels of miR&#x02010;1 and miR&#x02010;208 were increased</td><td align="left" rowspan="1" colspan="1">As a novel urine biomarker for acute myocardial infarction</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial infarction</td><td align="left" rowspan="1" colspan="1">Plasma</td><td align="left" rowspan="1" colspan="1">APOD, APOC3, C1Q1A, C5, GP1BA, PPBP</td><td align="left" rowspan="1" colspan="1">Protein markers that can be used as biomarkers of myocardial injury</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Doxorubicin&#x02010;induced cardiac injury</td><td align="left" rowspan="1" colspan="1">Cardiomyocyte</td><td align="left" rowspan="1" colspan="1">Glycogen phosphorylase B</td><td align="left" rowspan="1" colspan="1">Protein biomarkers of early heart injury</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart failure</td><td align="left" rowspan="1" colspan="1">Cardiomyocytes and endothelium</td><td align="left" rowspan="1" colspan="1">Trans&#x02010;coronary EVs concentration gradients</td><td align="left" rowspan="1" colspan="1">As a potential biomarker associated with pathophysiology in heart failure</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Systemic inflammatory response syndrome</td><td align="left" rowspan="1" colspan="1">Cardiomyocyte</td><td align="left" rowspan="1" colspan="1">Number of cyclic EVs</td><td align="left" rowspan="1" colspan="1">Reflects cardiac damage in lipopolysaccharide&#x02010;induced systemic inflammation</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Non&#x02010;valvular atrial fibrillation</td><td align="left" rowspan="1" colspan="1">Blood</td><td align="left" rowspan="1" colspan="1">miR&#x02010;106b&#x02010;3p, miR&#x02010;590&#x02010;5p, miR&#x02010;339&#x02010;3p, miR&#x02010;378&#x02010;3p, miR&#x02010;328&#x02010;3p, and miR&#x02010;532&#x02010;3p</td><td align="left" rowspan="1" colspan="1">Develop the novel biomarkers for diagnosis or monitoring the patients with the high risk of atrial fibrillation</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref>
</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>EVs carrying specific miRNAs have demonstrated their potential as diagnostic and prognostic markers in various clinical settings. The presence of exosomes in the plasma of critical patients suggests their potential utility in both diagnosis and treatment.<xref rid="mco2454-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref> Circulating miRNAs released by the damaged myocardium after MI can be transported to distant organs via exosomes.<xref rid="mco2454-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> Plasma circulating miRNAs are highly specific to heart injury and can be used as biomarkers for early diagnosis of MI. Research has shown that EVs are discharged from the myocardium during I/R injury, carrying heart&#x02010; and muscle&#x02010;specific miRNAs that can be rapidly identified in plasma. Because these EVs are rich in miRNAs and their detection precedes conventional injury markers, they have great potential as specific early biomarkers of myocardial injury.<xref rid="mco2454-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> miR&#x02010;1 and miR&#x02010;208 levels were significantly elevated in the urine of patients with AMI and the blood exosomes of rats after AMI and could be used as novel urine biomarkers.<xref rid="mco2454-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> In addition, six proteins belonging to lipid metabolism (apolipoproteins D [APOD] and C3 [APOC3]), complement activation (complement C1q subcomponent subunit A [C1QA] and C5), and platelet activation pathway (glycoprotein Ib platelet subunit alpha [GP1BA] and pro&#x02010;platelet basic protein [PPBP]) were identified as biomarkers of myocardial injury in proteomics analysis of plasma&#x02010;derived EVs from patients with MI. These findings suggest that EVs in the plasma show promise as a novel biomarker for diagnosis and as a therapeutic target, which could be refined for future clinical use.<xref rid="mco2454-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> Moreover, serum EVs extracted from a mouse model of doxorubicin (DOX)&#x02010;induced heart injury showed that those released by cardiomyocytes contained glycogen phosphorylase B (PYGB), a protein biomarker of early heart injury.<xref rid="mco2454-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>
</p><p>HF is a common and severe clinical condition that arises when the heart fails to supply sufficient blood flow to meet the body's metabolic needs or receive systemic venous return. HF is caused by myocardial damage due to various factors, including ischemic heart disease, hypertension, and diabetes.<xref rid="mco2454-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref> Due to HF's intricate clinical and mechanistic nature, investigating biomarkers that may provide crucial pathophysiological information and therapies to mitigate cardiac injury is of utmost importance. EVs have also been shown to be a potential biomarker associated with HF pathophysiology. In patients with HF phenotypes undergoing elective coronary artery bypass surgery, EV release curves from different cell sources might indicate myocardial injury and stress states.<xref rid="mco2454-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref> Additionally, EVs originating from myocardial cells can be found in the bloodstream. The elevated levels of cardio&#x02010;derived EVs in the circulation indicate cardiac injury in the context of lipopolysaccharide&#x02010;induced systemic inflammation.<xref rid="mco2454-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> Non&#x02010;valvular AF is the most common type of arrhythmia. Compared with the non AF control group, there are six highly expressed miRNAs in EVs of AF patients (miR&#x02010;106b&#x02010;3p, miR&#x02010;590&#x02010;5p, miR&#x02010;339&#x02010;3p, miR&#x02010;378&#x02010;3p, miR&#x02010;328&#x02010;3p, and miR&#x02010;532&#x02010;3p), which may become new biomarkers for diagnosing or monitoring high&#x02010;risk AF patients.<xref rid="mco2454-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref>
</p><p>In summary, EVs play an important role in the study of the pathogenesis and diagnostic markers of CVDs. In addition, further research on the therapeutic effects of EVs from different cell sources on CVDs is also of great significance.</p></sec></sec><sec id="mco2454-sec-0050"><label>3</label><title>EVS DERIVED FROM DIFFERENT CELL TYPES PROMOTE THE TREATMENT OF CVDS</title><p>Research has shown that the myocardial tissue can release EVs, which could be a significant means of intercellular communication beyond the confines of the heart.<xref rid="mco2454-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref> EVs are submicron&#x02010;sized lipid envelopes that are produced and released from parent cells and can be taken up by recipient cells. EVs are able to mediate cell signaling by carrying nucleic acids, proteins, lipids, and cellular metabolites between cells and organs,<xref rid="mco2454-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref> and the endogenous properties of these vesicles allow them to survive in the extracellular space, bypass biological barriers and deliver their bioactive molecular cargo to recipient cells.<xref rid="mco2454-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> EVs from non&#x02010;cardiac cells and platelets in the circulation, and those from various cardiovascular cell types, may specifically target cardiovascular structures where they can mitigate myocardial injury, while EVs of cardiovascular origin may also be cyclically transferred to distant tissues.<xref rid="mco2454-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref> Moreover, previous studies have shown that when mesenchymal stem cells (MSCs) are transplanted into the heart after AMI or I/R injury, infarct size and cardiac function improved, accompanied by a decrease in myocardial cell death.<xref rid="mco2454-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> However, using MSCs during post&#x02010;ischemic cardiac functional recovery has great uncertainty and controversial efficacy, limiting their application prospects, which the paracrine properties of MSCs can overcome. Many studies have used modified MSCs and MSC&#x02010;EVs to treat myocardial injury and achieved significant results.<xref rid="mco2454-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref> As an alternative to cell therapy, EVs have made significant research progress. Studying EVs can help explore the communication between the damaged myocardium and other tissues and organs to initiate the myocardial repair process. In addition, the potential mechanisms of how cardiomyocytes/stem cells repair and regenerate myocardial injury after CVDs can be further elucidated.</p><sec id="mco2454-sec-0060"><label>3.1</label><title>Mechanism of cardiovascular cell&#x02010;derived EVs in treating CVDs</title><sec id="mco2454-sec-0070"><label>3.1.1</label><title>EVs derived from cardiomyocytes</title><p>Cardiomyocytes, ECs, macrophages, and fibroblasts are the primary sources of EVs in the heart<xref rid="mco2454-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref> (Figure&#x000a0;<xref rid="mco2454-fig-0002" ref-type="fig">2</xref>). Studies have shown that AMI temporarily increases the production of cardiac EVs, and EVs accumulated in ischemic myocardium are rapidly absorbed by infiltrated monocytes and regulate local inflammatory responses.<xref rid="mco2454-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref> Besides, EVs from human heart&#x02010;derived adherent proliferative (CardAP) cells can direct CD14 immune cells to a regulated type that promotes regeneration of damaged heart tissue by limiting unnecessary inflammatory processes.<xref rid="mco2454-bib-0062" ref-type="bibr">
<sup>62</sup>
</xref> The transcription factor hypoxia&#x02010;inducing factor 1&#x003b1; (HIF&#x02010;1&#x003b1;) plays a crucial role in the adaptive response to hypoxia since it is stimulated by low oxygen levels. Myocytes reportedly release miR&#x02010;30a&#x02010;rich EVs in response to HIF&#x02010;1&#x003b1; to protect the myocardium from damage. miR&#x02010;30a&#x02010;rich EVs have also been associated with the mechanism of action of downregulating autophagy&#x02010;related proteins, such as autophagy&#x02010;related 12 (<italic toggle="yes">ATG12</italic>), beclin 1 (<italic toggle="yes">BECN1</italic>), and <italic toggle="yes">LC3II</italic>/<italic toggle="yes">LC3I</italic>.<xref rid="mco2454-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref> In addition, exosomal lncRNA KLF3 antisense RNA 1 (<italic toggle="yes">KLF3&#x02010;AS1</italic>) from ischemic cardiomyocytes can rescue myocardial cell damage in vitro and in vivo and inhibit myocardial I/R damage by upregulating signal transducer and activator of transcription 5B (<italic toggle="yes">STAT5B</italic>) expression and mediating insulin&#x02010;like growth factor 1 (IGF&#x02010;1) secretion by MSCs.<xref rid="mco2454-bib-0064" ref-type="bibr">
<sup>64</sup>
</xref> It has also been shown that myocardial miRNA (myo&#x02010;miR) is released into circulation via exosomes after AMI, mediating functional crosstalk between the ischemic heart and bone marrow (BM). Circulating levels of myo&#x02010;miR were elevated in a mouse model of AMI. In addition, the circulating exosomes in this model primarily contained miR&#x02010;1, miR&#x02010;208, and miR&#x02010;499, which can downregulate C&#x02013;X&#x02013;C motif chemokine receptor 4 (<italic toggle="yes">CXCR4</italic>) expression in BM monocytes, leading to an increase in the number of circulating progenitor cells (PCs). Therefore, the myo&#x02010;miR transported by circulating exosomes can stimulate a systemic response to cardiac injury and has potential applications in cardiac repair.<xref rid="mco2454-bib-0065" ref-type="bibr">
<sup>65</sup>
</xref>
</p><fig position="float" fig-type="FIGURE" id="mco2454-fig-0002"><label>FIGURE 2</label><caption><p>The main mechanism of extracellular vesicles (EVs) derived from different kinds of cardiac cells to promote the repair of cardiovascular diseases (CVDs). EVs derived from cardiac structure&#x02010;related cells, such as damaged&#x02010;cardiomyocyte and endothelial cells (ECs), promote the repair of CVDs by regulating related signaling pathways. EVs derived from inflammation&#x02010;related cells, such as macrophage and polymorphonuclear cells (PMNs), promote the repair of CVDs by regulating related signaling pathways. EVs derived from proliferation&#x02010;related cells, such as mesenchymal stem cells (MSCs), promote the repair of CVDs by regulating related signaling pathways. EVs derived from differentiation&#x02010;related cells, such as cardiac progenitor cells (CPCs) and cardiosphere&#x02010;derived cells (CDCs), promote the repair of CVDs by regulating related signaling pathways. The green arrow represents the promotion of CVDs repair.</p></caption><graphic xlink:href="MCO2-4-e454-g003" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="mco2454-sec-0080"><label>3.1.2</label><title>EVs derived from ECs</title><p>ECs comprise the innermost layer of the cardiovascular system and play a crucial role in maintaining the structure and function of the heart and blood vessels. Studies have shown that EVs released by ECs can reduce myocardial cell death after H/R by activating the extracellular signal&#x02010;regulated kinases 1/2 (ERK1/2)&#x02013;mitogen&#x02010;activated protein kinase (MAPK) signaling pathway, suggesting that EC&#x02010;EVs might have the potential to improve tissue damage in different CVDs.<xref rid="mco2454-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref> Another study showed that EVs derived from human umbilical vein ECs could carry miR&#x02010;129 and reduce myocardial I/R damage by downregulating Toll&#x02010;like receptor 4 (<italic toggle="yes">TLR4</italic>) and disrupting nuclear factor kappa B (NF&#x02010;&#x003ba;B) signaling.<xref rid="mco2454-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref> Other studies have found that EC&#x02010;EVs contain various protective proteins, which may save I/R damage in the human heart&#x02010;on&#x02010;a&#x02010;chip by providing proteins regulating metabolism and rescue pathways to injured cardiomyocytes.<xref rid="mco2454-bib-0068" ref-type="bibr">
<sup>68</sup>
</xref> In addition, vascular ECs produce exosomal long intergenic non&#x02010;protein coding RNA 174 (<italic toggle="yes">LINC00174</italic>), which can suppress p53&#x02010;mediated autophagy and apoptosis to alleviate I/R injury. These findings suggest that targeting <italic toggle="yes">LINC00174</italic> could be promising for treating I/R&#x02010;induced MI.<xref rid="mco2454-bib-0069" ref-type="bibr">
<sup>69</sup>
</xref> Both internal and external factors can influence the secretion of exosomes or their contents. Notably, shockwave therapy has been shown to stimulate the release of exosomes.<xref rid="mco2454-bib-0070" ref-type="bibr">
<sup>70</sup>
</xref> Extracorporeal cardiac shock wave (ECSW) represents a novel, non&#x02010;invasive, safe, and effective approach to managing CVDs. Studies have shown that ECSW can effectively stimulate endothelial colony&#x02010;forming cell&#x02010;derived exosomes in vitro. The delivery of exosomal miR&#x02010;140&#x02010;3p induced by ECSW can lead to a more potent therapeutic effect on H9C2 cells following H/R&#x02010;induced injury, which may represent a promising strategy for treating myocardial IR injury.<xref rid="mco2454-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref>
</p></sec><sec id="mco2454-sec-0090"><label>3.1.3</label><title>EVs derived from the epicardium</title><p>The epicardium is the outermost layer of the heart. It can provide various cardiovascular cells for the formation of the heart and is the source of nutritional signals that promote the growth of the heart muscle during embryonic development.<xref rid="mco2454-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref> Epicardial EVs have been isolated from mouse and human sources, showing that epicardial EVs act as signaling molecules, promoting the proliferation of cardiomyocytes in mouse hearts with infarction and in models of human myocardial injury, thereby enhancing cardiac function. Moreover, next&#x02010;generation RNA sequencing showed conserved miRNAs in the human and mouse epicardial exosomes, such as miR&#x02010;30a, miR&#x02010;100, miR&#x02010;27a, and miR&#x02010;30e.<xref rid="mco2454-bib-0073" ref-type="bibr">
<sup>73</sup>
</xref>
</p></sec><sec id="mco2454-sec-0100"><label>3.1.4</label><title>EVs derived from macrophages and polymorphonuclear cells</title><p>Studies have shown that EVs derived from M2 macrophages can inhibit ELAV&#x02010;like RNA binding protein 1 (<italic toggle="yes">ELAVL1</italic>/<italic toggle="yes">HuR</italic>) expression via miR&#x02010;378a&#x02010;3p and block the activation of NLR family pyrin domain containing 3 (NLRP3)/caspase 1 (CASP1)/gasdermin D (GSDMD) pathway, thereby reducing myocardial pyrodeath, and restoring cardiac function in mice with MI.<xref rid="mco2454-bib-0074" ref-type="bibr">
<sup>74</sup>
</xref> Additional studies have shown that exosomes derived from M2 macrophages contain miR&#x02010;148a, which can mitigate myocardial I/R injury by suppressing the thioredoxin interacting protein (TXNIP) and TLR4/NF&#x02010;&#x003ba;B/NLRP3 inflammasome signaling pathways.<xref rid="mco2454-bib-0075" ref-type="bibr">
<sup>75</sup>
</xref> In addition, M2&#x02010;macrophage&#x02010;derived exosomes contain miR&#x02010;1271&#x02010;5p, which can alleviate cardiac damage in AMI by downregulating SRY&#x02010;box transcription factor 6 (<italic toggle="yes">SOX6</italic>).<xref rid="mco2454-bib-0076" ref-type="bibr">
<sup>76</sup>
</xref> Moreover, polymorphonuclear cells (PMNs) are important inflammatory cells, and studies have shown that calcium&#x02010;sensitive receptors (CaSRs) regulate the proinflammatory effects of PMNs. Studies have shown that PMN&#x02010;derived exosomes from CaSR stimulation play a pivotal role in AMI models and myocardial reperfusion injury. This effect may be associated with the protein kinase B (AKT) signaling pathway.<xref rid="mco2454-bib-0077" ref-type="bibr">
<sup>77</sup>
</xref>
</p></sec><sec id="mco2454-sec-0110"><label>3.1.5</label><title>EVs derived from fibroblasts</title><p>The cardioprotective effects of post&#x02010;ischemic regulation are mediated by exosomal miR&#x02010;423&#x02010;3p originating from cardiac fibroblasts, protecting cardiomyocytes from H/R damage.<xref rid="mco2454-bib-0078" ref-type="bibr">
<sup>78</sup>
</xref> Moreover, overexpression of GATA binding protein 4 (<italic toggle="yes">GATA4</italic>) enhanced the protective effects of exosomes secreted by cardiac colony&#x02010;forming unit fibroblasts against myocardial ischemic injury via the miR&#x02010;221&#x02010;mediated phosphatase and tensin homolog (PTEN)/phosphoinositide 3&#x02010;kinase (PI3K)/AKT signaling pathway.<xref rid="mco2454-bib-0079" ref-type="bibr">
<sup>79</sup>
</xref>
</p></sec><sec id="mco2454-sec-0120"><label>3.1.6</label><title>EVs derived from regeneration&#x02010;associated cells</title><p>Discovering novel approaches for converting cardiomyocytes into a regenerative state is a significant therapeutic objective, given that the heart has limited regenerative potential to repair damaged tissue following a MI, which may subsequently result in additional HF.<xref rid="mco2454-bib-0080" ref-type="bibr">
<sup>80</sup>
</xref> When a myocardial injury requires angiogenesis, proinflammatory cell subsets of peripheral blood monocytes change their phenotype to pro&#x02010;regenerative cells, such as angiogenic endothelial PCs, M2 macrophages, and regulatory T cells (Tregs), collectively known as regeneration&#x02010;associated cells (RACs).<xref rid="mco2454-bib-0081" ref-type="bibr">
<sup>81</sup>
</xref> EVs secreted by RACs contribute to angiogenesis, anti&#x02010;fibrosis, anti&#x02010;inflammation, and cardiomyogenesis. They can preferentially accumulate in the I/R&#x02010;injured myocardium and contribute to the recovery of cardiac function after ischemia&#x02010;induced injury.<xref rid="mco2454-bib-0082" ref-type="bibr">
<sup>82</sup>
</xref>
</p></sec><sec id="mco2454-sec-0130"><label>3.1.7</label><title>EVs derived from cardiac PCs</title><p>Cardiac PCs (CPCs) are stationary cells under normal physiological conditions, but they are activated and have the potential to differentiate into cardiac cells after cardiac injury. Treating mouse models of I/R injury and mouse myocardial cells with CPC&#x02010;derived EVs reduced myocardial cell apoptosis.<xref rid="mco2454-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref> In addition, EVs from human CPCs suppressed myocardial cell apoptosis and enhanced cardiac function post&#x02010;injury.<xref rid="mco2454-bib-0084" ref-type="bibr">
<sup>84</sup>
</xref> In vitro and in vivo studies have shown that EVs derived from CPCs can ameliorate cardiac function and reduce fibrosis. This protective effect of cardiomyocytes is mediated by post&#x02010;transcriptional regulation of miR&#x02010;21 by <italic toggle="yes">PDCD4</italic>.<xref rid="mco2454-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref> Elevated <italic toggle="yes">CXCR4</italic> levels in CPC&#x02010;derived exosomes has been shown to improve the efficacy and bioavailability of cardio&#x02010;protective CPC exosomes and improve cardiac function in rat models with I/R injury.<xref rid="mco2454-bib-0086" ref-type="bibr">
<sup>86</sup>
</xref> Additionally, the migration of PCs and other supportive cells from the BM to the ischemic injured heart is a natural reparative response. Clinical trials of cell therapy using BM&#x02010;PCs have demonstrated its therapeutic effect on ischemic heart disease.<xref rid="mco2454-bib-0087" ref-type="bibr">
<sup>87</sup>
</xref>
</p></sec><sec id="mco2454-sec-0140"><label>3.1.8</label><title>EVs derived from cardiosphere&#x02010;derived cells</title><p>Several studies have indicated that using exosomes released by cardiosphere&#x02010;derived cells (CDCs) may serve as a viable cell&#x02010;free therapy for CVDs. Arrhythmogenic cardiomyopathy (ACM) is an inherited heart disease characterized by progressive loss of cardiomyocytes and replacement of fibrous adipose tissue.<xref rid="mco2454-bib-0088" ref-type="bibr">
<sup>88</sup>
</xref> It has been shown that EVs derived from CDCs mitigated ACM in desmoglein&#x02010;2 mutant mice, improved heart function, reduced cardiac inflammation, and inhibited the occurrence of arrhythmias.<xref rid="mco2454-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref> Moreover, in two distinct porcine models, the acute administration of CDC&#x02010;derived exosomes reduced myocardial injury, reduced scar formation, mitigated adverse cardiac remodeling, and improved function in both acute and chronic MI phases. These findings support the potential use of CDC&#x02010;derived exosomes as a promising therapeutic strategy for MI.<xref rid="mco2454-bib-0090" ref-type="bibr">
<sup>90</sup>
</xref> Furthermore, studies have shown that intravenous CDC&#x02010;EVs accumulate primarily in the heart and that cardiac injury enhances the uptake of CDC&#x02010;EVs by the heart, liver, and brain.<xref rid="mco2454-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref> Additional studies have proposed that CDCs might be more efficacious than MSCs in MI models. In vitro, CDC&#x02010;derived EVs have been shown to elevate the arginase 1 (<italic toggle="yes">ARG1</italic>)/nitric oxide synthase 2 (<italic toggle="yes">NOS2</italic>) ratio in macrophages, leading to a greater reduction in MI size than MSC&#x02010;derived EVs. Moreover, in animal models, CDC&#x02010;derived EVs have shown protective effects against ischemic myocardial injury and acute inflammation.<xref rid="mco2454-bib-0092" ref-type="bibr">
<sup>92</sup>
</xref>
</p><p>In summary, EVs derived from various sources can promote the repair of CVDs. They include those from cardiomyocytes, ECs, and epicardium that maintain cardiac structure; those from macrophages that regulate the cardiac inflammatory response; those from fibroblasts and RACs that promote cardiac regeneration and repair; and those from CPCs and CDCs that have proliferation and differentiation functions.</p></sec></sec><sec id="mco2454-sec-0150"><label>3.2</label><title>Mechanism of stem cell&#x02010;derived EVs in treating CVDs</title><sec id="mco2454-sec-0160"><label>3.2.1</label><title>EVs derived from BMSCs</title><p>MSCs can differentiate into ECs, heart cells, or vascular smooth muscle cells. Many studies have shown that stem cells may act by releasing EVs with cardio&#x02010;protective properties<xref rid="mco2454-bib-0093" ref-type="bibr">
<sup>93</sup>
</xref> (Figure&#x000a0;<xref rid="mco2454-fig-0003" ref-type="fig">3</xref>). BMSCs are one of the most common cell types used in cardiomyocyte therapeutic research because of their relatively easy availability, high proliferation, and anti&#x02010;inflammatory and low immunogenic properties.<xref rid="mco2454-bib-0094" ref-type="bibr">
<sup>94</sup>
</xref>
</p><fig position="float" fig-type="FIGURE" id="mco2454-fig-0003"><label>FIGURE 3</label><caption><p>The main mechanism of extracellular vesicles (EVs) derived from different kinds of stem cells to promote the repair of cardiovascular diseases (CVDs). EVs derived from bone marrow mesenchymal stem cells (BMSCs) can promote cardiac repair by reducing inflammation, inhibiting apoptosis, and regulating autophagy. EVs derived from other types of stem cells, such as adipose tissue mesenchymal stem cells (ADSCs), human umbilical cord&#x02010;derived mesenchymal stem cells (HUCMSCs), cardiac mesenchymal stem cells (C&#x02010;MSCs), trophoblast stem cells (TSCs), and neural stem cells (NSCs) can promote CVDs repair by regulating related signaling pathways. EVs derived from induced pluripotent stem cells (iPSCs) or differentiated iPSCs promote the repair of CVDs through microRNA (miRNA) and long non&#x02010;coding RNA (lncRNA) delivery. The green arrow represents the promotion of CVDs repair.</p></caption><graphic xlink:href="MCO2-4-e454-g002" position="anchor" id="jats-graphic-7"/></fig><p>MSCs&#x02010;derived EVs play an important role in the progression of inflammation associated with CVDs. Studies have shown that MSC&#x02010;derived exosomes have immunomodulatory effects on macrophages in myocardial I/R injury models and inhibit <italic toggle="yes">TLR4</italic> activity mainly through the delivery of exosomal miR&#x02010;182, generating potential effects in treating myocardial I/R injury.<xref rid="mco2454-bib-0095" ref-type="bibr">
<sup>95</sup>
</xref> Other studies have shown that MSC&#x02010;derived exosomes containing miR&#x02010;182&#x02010;5p ameliorated cardiac function and reduced MI in mice by targeting <italic toggle="yes">GSDMD</italic> and reducing inflammation and pyroptosis in vivo.<xref rid="mco2454-bib-0096" ref-type="bibr">
<sup>96</sup>
</xref> In addition, MSC&#x02010;derived exosomes modulated macrophage polarization and suppressed inflammatory responses via miR&#x02010;21&#x02010;5p, promoting myocardial repair following reperfusion injury.<xref rid="mco2454-bib-0097" ref-type="bibr">
<sup>97</sup>
</xref> Moreover, the enrichment of miR&#x02010;100&#x02010;5p in human umbilical cord&#x02010;derived MSC (hUCMSC)&#x02010;derived exosomes inhibits forkhead box O3 (<italic toggle="yes">FOXO3</italic>) expression, <italic toggle="yes">NLRP3</italic> inflammasome activation, and cytokine release, protecting cardiomyocytes from H/R&#x02010;induced pyrodeath and injury.<xref rid="mco2454-bib-0098" ref-type="bibr">
<sup>98</sup>
</xref> Besides, milk fat globule&#x02010;epidermal growth factor&#x02010;factor VIII (MFGE8) in MSCs&#x02010;derived exosomes activates phagocytosis signaling, which enhances the removal of apoptotic cells and the resolution of inflammation, thus effectively repairing the heart.<xref rid="mco2454-bib-0099" ref-type="bibr">
<sup>99</sup>
</xref>
</p><p>MSC&#x02010;derived EVs can also reduce apoptosis, promote cell proliferation, and thus reduce myocardial damage. MSC&#x02010;derived EVs can improve angiogenesis and play a therapeutic role in MI by delivering miR&#x02010;210.<xref rid="mco2454-bib-0100" ref-type="bibr">
<sup>100</sup>
</xref> In addition, miR&#x02010;221 delivered by MSC&#x02010;derived EVs inhibited atherosclerotic plaque formation in atherosclerotic model mice.<xref rid="mco2454-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref> Other studies have found that lncRNA A2M antisense RNA 1 (<italic toggle="yes">A2M&#x02010;AS1</italic>) can reduce H/R&#x02010;induced myocardial apoptosis and oxidative stress by regulating miR&#x02010;556&#x02010;5p/X&#x02010;linked inhibitor of apoptosis (XIAP) via the delivery of MSC&#x02010;derived exosomes, regulating myocardial I/R injury.<xref rid="mco2454-bib-0102" ref-type="bibr">
<sup>102</sup>
</xref> Moreover, studies have shown that the presence of miR&#x02010;486&#x02010;5p in BMSC&#x02010;derived exosomes activates the PI3K/AKT signaling pathway by suppressing <italic toggle="yes">PTEN</italic> expression, inhibiting the apoptosis of injured cardiomyocytes and protecting against myocardial ischemic injury.<xref rid="mco2454-bib-0103" ref-type="bibr">
<sup>103</sup>
</xref> MSC&#x02010;derived exosomes were shown to be more effective in treating MI in rats when combined with interferon&#x02010;&#x003b3; through the action of miR&#x02010;21, which promoted angiogenesis and reduced apoptosis, protecting against myocardial injury.<xref rid="mco2454-bib-0104" ref-type="bibr">
<sup>104</sup>
</xref> In addition, lncRNA HLA complex P5 (<italic toggle="yes">HCP5</italic>) in human BMSC&#x02010;derived exosomes alleviates myocardial I/R injury by activating the IGF&#x02010;1/PI3K/AKT pathway by sponging miR&#x02010;497.<xref rid="mco2454-bib-0105" ref-type="bibr">
<sup>105</sup>
</xref>
</p><p>While autophagy is a mechanism that can maintain cell viability by eliminating damaged organelles through ATP degradation under mild ischemic stress, it can exacerbate cardiac dysfunction and induce cell death when activated under severe ischemic conditions.<xref rid="mco2454-bib-0106" ref-type="bibr">
<sup>106</sup>
</xref> Studies have shown that MSCs transplantation therapy improved cardiac function and infarct size in infarcted mouse hearts, primarily through exosomes containing miR&#x02010;125b&#x02010;5p, while reducing apoptosis and autophagy flux.<xref rid="mco2454-bib-0107" ref-type="bibr">
<sup>107</sup>
</xref> In addition, MSC&#x02010;derived exosomal miR&#x02010;143&#x02010;3p&#x02010;regulated autophagy through the checkpoint kinase 2 (CHEK2/CHK2)/beclin 2 (BECN2) pathway, effectively reducing apoptosis and inhibiting myocardial I/R injury.<xref rid="mco2454-bib-0108" ref-type="bibr">
<sup>108</sup>
</xref>
</p></sec><sec id="mco2454-sec-0170"><label>3.2.2</label><title>EVs derived from hypoxic preconditioned BMSCs</title><p>Subjecting heart cells to hypoxic preconditioning can improve and strengthen their ability to withstand and adjust to hypoxia, inflammation, and oxidative stress. Studies have shown that compared with EVs secreted by normoxic MSCs, EVs secreted by hypoxic&#x02010;preconditioned MSCs may better prevent myocardial I/R injury, and the direct binding of miR&#x02010;224&#x02010;5p in EVs with <italic toggle="yes">TXNIP</italic> is a key protective mechanism against myocardial cell death.<xref rid="mco2454-bib-0109" ref-type="bibr">
<sup>109</sup>
</xref> EVs from hypoxic&#x02010;preconditioned MSCs have also been shown to reduce myocardial injury by targeting the <italic toggle="yes">TXNIP</italic>&#x02010;mediated HIF&#x02010;1&#x003b1; pathway.<xref rid="mco2454-bib-0110" ref-type="bibr">
<sup>110</sup>
</xref> In addition, exosomal miR&#x02010;98&#x02010;5p from hypoxic BMSCs inhibited myocardial I/R injury by decreasing <italic toggle="yes">TLR4</italic> expression and activating the PI3K/AKT signaling pathway.<xref rid="mco2454-bib-0111" ref-type="bibr">
<sup>111</sup>
</xref> Other studies have found that lncRNA urothelial cancer associated 1 (<italic toggle="yes">UCA1</italic>) in MSC&#x02010;derived exosomes secreted under hypoxic conditions provides cardiac protection through the miR&#x02010;873&#x02010;5p/XIAP axis.<xref rid="mco2454-bib-0112" ref-type="bibr">
<sup>112</sup>
</xref> Moreover, cardiac hypertrophy is a pathological myocardial remodeling process in a variety of CVDs, characterized by cardiomyocyte hypertrophy, interstitial fibrosis, and decreased myocardial compliance.<xref rid="mco2454-bib-0113" ref-type="bibr">
<sup>113</sup>
</xref> Parkinson disease protein 7 (PARK7/DJ&#x02010;1) contained in EVs derived from hypoxic MSCs alleviates cardiac hypertrophy by inhibiting mitochondrial dysfunction and preventing AT1R&#x02010;associated protein (ATRAP) degradation.<xref rid="mco2454-bib-0114" ref-type="bibr">
<sup>114</sup>
</xref>
</p></sec><sec id="mco2454-sec-0180"><label>3.2.3</label><title>EVs derived from other types of stem cells</title><p>Using exosomes derived from adipose tissue MSCs (ADSCs) safeguarded rat myocardium against I/R injury via activation of the Wnt/&#x003b2;&#x02010;catenin signaling pathway.<xref rid="mco2454-bib-0115" ref-type="bibr">
<sup>115</sup>
</xref> Moreover, studies have shown that ADSC&#x02010;derived exosomes prevent heart I/R injury via miR&#x02010;221/miR&#x02010;222 targeting the B&#x02010;cell leukemia&#x02010;lymphoma 2 (BCL2)&#x02010;binding component 3 (BBC3/PUMA)/ETS proto&#x02010;oncogene 1 transcription factor (ETS1) pathway and are effective inhibitors of I/R&#x02010;induced heart injury.<xref rid="mco2454-bib-0116" ref-type="bibr">
<sup>116</sup>
</xref> In addition, ADSC&#x02010;derived exosomes prevent oxidative stress&#x02010;induced cardiomyocyte apoptosis and have cardioprotective effects against I/R injury.<xref rid="mco2454-bib-0117" ref-type="bibr">
<sup>117</sup>
</xref>
</p><p>Human umbilical cord&#x02010;derived mesenchymal stem cell (HUCMSC) derived exosomes were shown to alleviate the damage caused by AMI.<xref rid="mco2454-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref> MSC&#x02010;derived exosomes from human cord blood may inhibit solute carrier family 11 member 2 (<italic toggle="yes">SLC11A2</italic>/<italic toggle="yes">DMT1</italic>) expression and iron death through miR&#x02010;23a&#x02010;3p, alleviating myocardial injury in mice with AMI.<xref rid="mco2454-bib-0119" ref-type="bibr">
<sup>119</sup>
</xref> Viral myocarditis is a significant contributor to HF, arrhythmia, and sudden death in young individuals, and it is characterized by immune damage, viral infection&#x02010;induced autophagy, and apoptosis.<xref rid="mco2454-bib-0120" ref-type="bibr">
<sup>120</sup>
</xref> HUCMSC&#x02010;derived exosomes can alleviate coxsackievirus B3&#x02010;induced myocarditis by activating the AMP&#x02010;activated protein kinase (AMPK)/mechanistic target of rapamycin kinase (mTOR)&#x02010;mediated autophagy flux pathway, reducing myocardial cell apoptosis and significantly alleviating myocardial injury.<xref rid="mco2454-bib-0121" ref-type="bibr">
<sup>121</sup>
</xref> HUCMSC&#x02010;derived exosome transfer lncRNA <italic toggle="yes">UCA1</italic> alleviated I/R damage via the miR&#x02010;143/BCL2/BECN1 axis.<xref rid="mco2454-bib-0122" ref-type="bibr">
<sup>122</sup>
</xref> In addition, hUCMSC&#x02010;derived exosomes may promote SMAD family member 7 (<italic toggle="yes">SMAD7</italic>) expression and increase myocardial injury repair by inhibiting miR&#x02010;125b&#x02010;5p.<xref rid="mco2454-bib-0123" ref-type="bibr">
<sup>123</sup>
</xref> Moreover, hUCMSC&#x02010;derived exosomes protect myocardial cells from AMI damage by transferring miR&#x02010;19a to target <italic toggle="yes">SOX6</italic>, activating <italic toggle="yes">AKT</italic>, and inhibiting MAPK10/JNK3/CASP3 activation.<xref rid="mco2454-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref> The EVs secreted by human amniotic fluid mesenchymal stromal cells have the potential for cardiac protection and migration and can protect the heart of rats from I/R injury in vivo.<xref rid="mco2454-bib-0125" ref-type="bibr">
<sup>125</sup>
</xref>
</p><p>Cardiac MSCs (C&#x02010;MSCs) are a novel subgroup of MSCs derived from cardiac tissue.<xref rid="mco2454-bib-0126" ref-type="bibr">
<sup>126</sup>
</xref> Increasing evidence indicates that Notch signaling is reactivated during myocardial injury and triggers cardiac repair following such injury. Studies have used EVs released by notch receptor 1 (<italic toggle="yes">Notch1</italic>)&#x02010;overexpressing C&#x02010;MSCs to demonstrate their ability to prevent cell death, stimulate angiogenesis and myocardial cell proliferation, and ultimately restore cardiac function after MI.<xref rid="mco2454-bib-0127" ref-type="bibr">
<sup>127</sup>
</xref>
</p><p>Trophoblast stem cells (TSCs) originate from monolayer blastocysts during the earliest cell differentiation. Studies have shown that transplantation of cardiac TSCs can ameliorate incorrect myocardial remodeling and improve cardiac function.<xref rid="mco2454-bib-0128" ref-type="bibr">
<sup>128</sup>
</xref> TSC&#x02010;derived exosomes show anti&#x02010;apoptotic and anti&#x02010;inflammatory properties by regulating miR&#x02010;200b and its downstream target zinc finger E&#x02010;box binding homeobox 1 (<italic toggle="yes">ZEB1</italic>), alleviating DOX&#x02010;induced heart damage and offering a novel therapeutic approach for HF.<xref rid="mco2454-bib-0129" ref-type="bibr">
<sup>129</sup>
</xref> In addition, exosomes secreted by neural stem cells (NSCs) have been found to protect the heart against I/R injury by activating the JAK1/2 and interleukin 6 cytokine family signal transducer (IL6ST/GP130) signaling pathways.<xref rid="mco2454-bib-0130" ref-type="bibr">
<sup>130</sup>
</xref> Additional research has indicated that exosomes derived from cortical diaphyseal tissues have therapeutic potential for managing myocardial I/R injury and subsequent cardiac remodeling.<xref rid="mco2454-bib-0131" ref-type="bibr">
<sup>131</sup>
</xref>
</p></sec><sec id="mco2454-sec-0190"><label>3.2.4</label><title>EVs derived from embryonic stem cells, induced pluripotent stem cells, and cardiovascular PCs</title><p>The enormous potential of pluripotent stem cells, such as embryonic (ESCs) and induced pluripotent (iPSCs) stem cells, to differentiate into various cardiac cell types has made them a promising candidate for cardiac regeneration.<xref rid="mco2454-bib-0132" ref-type="bibr">
<sup>132</sup>
</xref> ESC&#x02010;derived exosomes have been shown to promote endogenous repair mechanisms and enhance cardiac function after MI.<xref rid="mco2454-bib-0133" ref-type="bibr">
<sup>133</sup>
</xref> Additionally, EVs secreted by cardiovascular progenitor cells (Pg) derived from ESCs can effectively treat congestive HF.<xref rid="mco2454-bib-0134" ref-type="bibr">
<sup>134</sup>
</xref>
</p><p>Other studies have shown that iPSC&#x02010;derived EVs confer protective properties on heart cells in vitro and induce angiogenesis and improve apoptosis in vivo. Due to their cell&#x02010;free nature, iPSC&#x02010;EVs are a safer alternative for treating patients with ischemic myocardial injury.<xref rid="mco2454-bib-0135" ref-type="bibr">
<sup>135</sup>
</xref> In addition, one study used magnetic resonance imaging to track the homing of iPSC&#x02010;derived magnetic EVs in different animal models of myocardial ischemia. Their findings showed that iPSC&#x02010;derived EVs showed a strong tropism toward the myocardial injury site and had significant protective effects.<xref rid="mco2454-bib-0136" ref-type="bibr">
<sup>136</sup>
</xref> Other studies have suggested that iPSCs in ischemic tissues showed robust proliferation and survival, and injection of iPSC&#x02010;derived exosomes into mouse ischemic myocardium could prevent myocardial I/R injury. Moreover, iPSC&#x02010;derived exosomes could provide cardiac protective miRNAs to H9C2 cardiomyocytes in vitro, including Nanog homeobox (<italic toggle="yes">NANOG</italic>)&#x02010;regulated miR&#x02010;21 and HIF&#x02010;1&#x003b1;&#x02010;regulated miR&#x02010;210. Therefore, iPSC&#x02010;derived exosomes represent a novel class of biological nanoparticles for treating myocardial I/R injury.<xref rid="mco2454-bib-0137" ref-type="bibr">
<sup>137</sup>
</xref>
</p><p>Furthermore, exosomes produced by cardiac cells derived from iPSCs enhanced myocardial recovery without elevating the incidence of arrhythmic complications, providing another therapeutic option for CVDs.<xref rid="mco2454-bib-0138" ref-type="bibr">
<sup>138</sup>
</xref> Studies have shown that iPSC&#x02010;derived cardiomyocytes (iCMs) could be directly applied to the injured myocardium (including in non&#x02010;human primates).<xref rid="mco2454-bib-0139" ref-type="bibr">
<sup>139</sup>
</xref> In addition, the miR&#x02010;106a&#x02010;363 cluster in EVs isolated from human iPSC&#x02010;derived iCMs exposed to hypoxia and normoxia conditions promoted endogenous myocardial damage repair in ischemic heart injury through the notch 3 (NOTCH3) pathway.<xref rid="mco2454-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref>
</p><p>Mitochondria&#x02010;rich EVs (M&#x02010;EVs) were isolated from the medium of iPSC&#x02010;derived iCMs. Intramuscular injection of these M&#x02010;EVs facilitated the transfer of their mitochondrial and non&#x02010;mitochondrial cargo into injured cardiomyocytes, improving cardiac function in mouse models of MI by restoring cellular bioenergy. The proposed method shows potential as a new and accurate treatment for mitochondria&#x02010;associated diseases, including HF.<xref rid="mco2454-bib-0141" ref-type="bibr">
<sup>141</sup>
</xref>
</p><p>Additionally, iPSC&#x02010;derived cardiovascular PCs (CVPCs) might promote the healing of MI by improving myocardial cell survival and promoting angiogenesis. The cardioprotective effect of CVPC&#x02010;derived EVs was enhanced by hypoxia regulation of CVPCs, and lncRNA metastasis&#x02010;associated lung adenocarcinoma transcript 1 (<italic toggle="yes">MALAT1</italic>) was beneficial to the cardioprotective effect of CVPC&#x02010;derived EVs by targeting miRNAs.<xref rid="mco2454-bib-0142" ref-type="bibr">
<sup>142</sup>
</xref> Moreover, myocyte globules derived from iPSCs also improved the recovery of myocardial injury in mice.<xref rid="mco2454-bib-0143" ref-type="bibr">
<sup>143</sup>
</xref>
</p></sec></sec><sec id="mco2454-sec-0200"><label>3.3</label><title>EVs from blood</title><sec id="mco2454-sec-0210"><label>3.3.1</label><title>EVs from serum</title><p>In addition to cardiac and stem cells, EVs from other sources also help regulate CVDs. Serum EVs obtained from patients with acute coronary syndrome conferred protection against myocardial I/R injury in vitro and in rat hearts, dependent on STAT3 phosphorylation.<xref rid="mco2454-bib-0144" ref-type="bibr">
<sup>144</sup>
</xref> Another study showed that serum exosomes obtained through ischemic preconditioning protected rat hearts from I/R injury by activating the PI3K/AKT signaling pathway.<xref rid="mco2454-bib-0145" ref-type="bibr">
<sup>145</sup>
</xref> Serum&#x02010;circulating exosomes also protected AMI by regulating the miR&#x02010;190a&#x02010;3p/CXCR4/C&#x02013;X&#x02013;C motif chemokine ligand 12 (CXCL12) pathway<xref rid="mco2454-bib-0146" ref-type="bibr">
<sup>146</sup>
</xref> (Table&#x000a0;<xref rid="mco2454-tbl-0002" ref-type="table">2</xref>).</p><table-wrap position="float" id="mco2454-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Mechanisms of other extracellular vesicle (EV) sources to repair myocardial damage.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Disease</th><th align="left" rowspan="1" colspan="1">Source of EVs</th><th align="left" rowspan="1" colspan="1">Regulation mechanism</th><th align="left" rowspan="1" colspan="1">Effects</th><th align="left" rowspan="1" colspan="1">Patient or animal model</th><th align="left" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Serum</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">DUSP6</italic> expression promotes STAT3 phosphorylation</td><td align="left" rowspan="1" colspan="1">Mediates the protective effects of the heart</td><td align="left" rowspan="1" colspan="1">Acute coronary syndrome patients and rat models</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0144" ref-type="bibr">
<sup>144</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Serum</td><td align="left" rowspan="1" colspan="1">Activate the PI3K/AKT signaling pathway</td><td align="left" rowspan="1" colspan="1">Improve heart function, reduce inflammatory cytokines production, reduce myocardial cell apoptosis, and relieve I/R injury</td><td align="left" rowspan="1" colspan="1">Ischemic preconditioning rats</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0145" ref-type="bibr">
<sup>145</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial infarction</td><td align="left" rowspan="1" colspan="1">Serum</td><td align="left" rowspan="1" colspan="1">miR&#x02010;190a&#x02010;3p is downregulated in circulating exosomes, regulating the miR&#x02010;190a&#x02010;3p/CXCR4/CXCL12 pathway</td><td align="left" rowspan="1" colspan="1">It has a protective effect on myocardial injury</td><td align="left" rowspan="1" colspan="1">Acute myocardial infarction mouse model</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0146" ref-type="bibr">
<sup>146</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Plasma</td><td align="left" rowspan="1" colspan="1">HSP70/TLR4 axis</td><td align="left" rowspan="1" colspan="1">Delivers the signal to the heart and prevents I/R injury</td><td align="left" rowspan="1" colspan="1">Adult rats and humans</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0148" ref-type="bibr">
<sup>148</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Plasma</td><td align="left" rowspan="1" colspan="1">miR&#x02010;130a&#x02010;3p targets and negatively regulates <italic toggle="yes">ATG16L1</italic> gene</td><td align="left" rowspan="1" colspan="1">It can relieve excessive myocardial autophagy and improve myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">I/R injury rat model</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0150" ref-type="bibr">
<sup>150</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Plasma</td><td align="left" rowspan="1" colspan="1">Regulation of EVs miRNAs (miR&#x02010;16&#x02010;5p, miR&#x02010;144&#x02010;3p, and miR&#x02010;451a)</td><td align="left" rowspan="1" colspan="1">Circulating EVs accumulate in injured myocardium and prevent I/R injury</td><td align="left" rowspan="1" colspan="1">Sprague&#x02013;Dawley rat model</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0154" ref-type="bibr">
<sup>154</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Plasma</td><td align="left" rowspan="1" colspan="1">Exosomes transfer miR&#x02010;24</td><td align="left" rowspan="1" colspan="1">Reduce cell apoptosis and reduce myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Remote ischemic regulation rat</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0155" ref-type="bibr">
<sup>155</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Plasma</td><td align="left" rowspan="1" colspan="1">Exosomal miR&#x02010;126a&#x02010;3p</td><td align="left" rowspan="1" colspan="1">Reduce myocardial I/R damage</td><td align="left" rowspan="1" colspan="1">I/R rat model</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0156" ref-type="bibr">
<sup>156</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Plasma</td><td align="left" rowspan="1" colspan="1">Exosomal miR&#x02010;342&#x02010;3p targets <italic toggle="yes">SOX6</italic> and <italic toggle="yes">TFEB</italic>, respectively</td><td align="left" rowspan="1" colspan="1">Inhibit cardiomyocyte apoptosis and autophagy</td><td align="left" rowspan="1" colspan="1">Sprague&#x02010;Dawley rats</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0157" ref-type="bibr">
<sup>157</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Coronary artery disease</td><td align="left" rowspan="1" colspan="1">Plasma</td><td align="left" rowspan="1" colspan="1">lncRNA AS1 in EVs is significantly upregulated and regulate the expression of VEGFA</td><td align="left" rowspan="1" colspan="1">Promote angiogenesis</td><td align="left" rowspan="1" colspan="1">Patients with coronary artery disease</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0147" ref-type="bibr">
<sup>147</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart failure</td><td align="left" rowspan="1" colspan="1">Plasma</td><td align="left" rowspan="1" colspan="1">Ischemic preconditioning exosomes activate survival kinase in heart tissue</td><td align="left" rowspan="1" colspan="1">May have a cardiac protective effect against heart failure after myocardial infarction</td><td align="left" rowspan="1" colspan="1">Rat model of heart failure</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0149" ref-type="bibr">
<sup>149</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Acute myocardial ischemic injury</td><td align="left" rowspan="1" colspan="1">Patient blood</td><td align="left" rowspan="1" colspan="1">Deletion of lncRNA <italic toggle="yes">HCG15</italic> in exosomes activates the NF&#x02010;&#x003ba;B/p65 and p38 pathways</td><td align="left" rowspan="1" colspan="1">Prevention of acute myocardial ischemic injury</td><td align="left" rowspan="1" colspan="1">I/R mouse model</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0151" ref-type="bibr">
<sup>151</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Peripheral blood</td><td align="left" rowspan="1" colspan="1">miR&#x02010;17&#x02010;3p regulates the expression of <italic toggle="yes">TIMP3</italic> in exosomes</td><td align="left" rowspan="1" colspan="1">Relief of programmed necrosis associated with I/R injury</td><td align="left" rowspan="1" colspan="1">I/R mouse model</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0152" ref-type="bibr">
<sup>152</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">HEK293 cells</td><td align="left" rowspan="1" colspan="1">Calcium ion carrier&#x02010;induced EVs regulate <italic toggle="yes">HO&#x02010;1</italic> in a TLR4&#x02010;independent manner</td><td align="left" rowspan="1" colspan="1">Inhibition of simulated I/R damage in cardiomyocyte derived cell lines</td><td align="left" rowspan="1" colspan="1">Cells</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0158" ref-type="bibr">
<sup>158</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">Adipocyte</td><td align="left" rowspan="1" colspan="1">EVs contain respiratory but oxygen&#x02010;impaired mitochondrial particles that regulate ROS</td><td align="left" rowspan="1" colspan="1">Protect myocardial cells from acute oxidative stress and inhibit myocardial I/R injury</td><td align="left" rowspan="1" colspan="1">I/R mouse model</td><td align="left" rowspan="1" colspan="1">
<xref rid="mco2454-bib-0159" ref-type="bibr">
<sup>159</sup>
</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="mco2454-tbl2-note-0001"><p>Abbreviations: AKT, protein kinase B; I/R, ischemia/reperfusion; lncRNA, long non&#x02010;coding RNA; NF&#x02010;&#x003ba;B, nuclear factor kappa B; PI3K, phosphoinositide 3&#x02010;kinase; ROS, reactive oxygen species; STAT3, signal transducer and activator of transcription 3; TLR4, Toll&#x02010;like receptor 4.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="mco2454-sec-0220"><label>3.3.2</label><title>EVs from plasma</title><p>Studies have shown endogenous plasma exosomes also have strong cardioprotective effects in CVDs models. LncRNA AS1 in plasma EVs in patients with CAD is significantly upregulated, regulating the expression of VEGFA in ECs, thereby promoting angiogenesis.<xref rid="mco2454-bib-0147" ref-type="bibr">
<sup>147</sup>
</xref> The heat shock protein 70 (HSP70)/TLR4 axis is a key pathway for exosome&#x02010;mediated cardiac protection.<xref rid="mco2454-bib-0148" ref-type="bibr">
<sup>148</sup>
</xref> Other studies have shown that plasma exosomes produced by ischemic preconditioning have cardioprotective effects in rat HF models, protecting the heart in vivo.<xref rid="mco2454-bib-0149" ref-type="bibr">
<sup>149</sup>
</xref> In addition, plasma&#x02010;derived EVs containing miR&#x02010;130a&#x02010;3p reduced excessive autophagy and ameliorated myocardial I/R injury through miR&#x02010;130a&#x02010;3p, which targets and inhibits the autophagy&#x02010;related gene autophagy&#x02010;related 16 like 1 (<italic toggle="yes">ATG16L1)</italic> in cardiomyocytes.<xref rid="mco2454-bib-0150" ref-type="bibr">
<sup>150</sup>
</xref> Moreover, the absence of lncRNA HLA complex group 15 (<italic toggle="yes">HCG15</italic>) in the exosomes of MI patients prevented AMI via the NF&#x02010;&#x003ba;B/p65 and p38 pathways.<xref rid="mco2454-bib-0151" ref-type="bibr">
<sup>151</sup>
</xref>
</p><p>The role of programmed necrosis in I/R injury is critical. Studies have shown that miR&#x02010;17&#x02010;3p in peripheral blood exosomes following cardiac I/R injury mitigated programmed necrosis and attenuated cardiac I/R injury in vivo by modulating TIMP metallopeptidase inhibitor 3 (<italic toggle="yes">TIMP3</italic>) expression.<xref rid="mco2454-bib-0152" ref-type="bibr">
<sup>152</sup>
</xref> In addition, remote ischemic regulation (RIPC) protects the heart from fatal ischemic injury. EVs released from the heart after I/R were necessary for RIPC cardiac protection, demonstrating the importance of vesicular transfer mechanisms in remote cardiac protection.<xref rid="mco2454-bib-0153" ref-type="bibr">
<sup>153</sup>
</xref> In addition, other studies have indicated that the beneficial impact of RIPC on the heart can be mediated through the plasma and facilitated by circulating EVs that accumulate in the damaged myocardium. The underlying mechanism involves the regulation of three miRNAs (miR&#x02010;16&#x02010;5p, miR&#x02010;144&#x02010;3p, and miR&#x02010;451a) within the EVs to prevent I/R injury.<xref rid="mco2454-bib-0154" ref-type="bibr">
<sup>154</sup>
</xref> In addition, RIPC&#x02010;induced production of plasma exosomes can reduce apoptosis and myocardial I/R injury by paracrine transfer of miR&#x02010;24.<xref rid="mco2454-bib-0155" ref-type="bibr">
<sup>155</sup>
</xref> Moreover, plasma exosomes in late RIPC can reduce myocardial I/R injury through exosomal miR&#x02010;126a&#x02010;3p.<xref rid="mco2454-bib-0156" ref-type="bibr">
<sup>156</sup>
</xref> Furthermore, miR&#x02010;342&#x02010;3p dysregulation in plasma exosomes during early recovery after AMI may cause impaired cardiac protective potential. By targeting <italic toggle="yes">SOX6</italic> and transcription factor EB (<italic toggle="yes">TFEB</italic>), miR&#x02010;342&#x02010;3p can enhance exosome&#x02010;mediated repair of cardiac injury by suppressing myocardial apoptosis and autophagy.<xref rid="mco2454-bib-0157" ref-type="bibr">
<sup>157</sup>
</xref>
</p></sec><sec id="mco2454-sec-0230"><label>3.3.3</label><title>EVs from in vitro cells</title><p>Transient activation of Toll&#x02010;like receptors is associated with cardiac protection, which can be achieved by blood&#x02010;derived EV therapy. However, it is difficult to isolate EVs from blood. Therefore, a cell model was established from which heart&#x02010;protective EVs could be isolated in a repeatable manner by inducing EV release by HEK293 cells using a calcium ion carrier A23187. EVs induced by a calcium ion carrier played a protective role in I/R injury by regulating heme oxygenase 1 (<italic toggle="yes">HMOX1/HO&#x02010;1</italic>) in a TLR4&#x02010;independent manner.<xref rid="mco2454-bib-0158" ref-type="bibr">
<sup>158</sup>
</xref> In addition, adipocytes release small EVs (sEVs) containing respirable but oxygen&#x02010;impaired mitochondrial particles, which enter the bloodstream and get absorbed by cardiomyocytes. This mechanism shields cardiomyocytes against acute oxidative stress, and the administration of sEVs curbed myocardial I/R injury in mice.<xref rid="mco2454-bib-0159" ref-type="bibr">
<sup>159</sup>
</xref>
</p><p>At present, EVs has become a promising treatment for CVDs. Due to the mechanism of EVs involvement in the treatment of CVDs and the limitations of its application in vivo, the modification of EVs and its combination with biomaterials have also attracted much attention.</p></sec></sec></sec><sec id="mco2454-sec-0240"><label>4</label><title>APPLICATION OF MODIFIED EVS IN TREATING CVDS</title><p>As a natural carrier, EVs can transport various biomolecules to specific tissues, protect their contents from degradation, and quickly transport drug molecules to the recipient cells. EVs have good biocompatibility without causing toxicity and adverse immune reactions.<xref rid="mco2454-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> In addition, the ligands on the surface of EVs achieve cell specificity by binding to the cell surface receptors on the target cells.<xref rid="mco2454-bib-0160" ref-type="bibr">
<sup>160</sup>
</xref> However, the clinical therapeutic effect of simply applying EVs is still lacking. Designing and optimizing EVs and improving their therapeutic effect is necessary to make them a new clinical therapy. Overexpression of therapeutic molecular genes, loading exogenous drugs, or enhancing EV targeting through membrane engineering can improve their therapeutic efficacy (Figure&#x000a0;<xref rid="mco2454-fig-0004" ref-type="fig">4</xref>). Combining EVs with hydrogels and other biological materials is also an important research direction for heart patches and heart stents.</p><fig position="float" fig-type="FIGURE" id="mco2454-fig-0004"><label>FIGURE 4</label><caption><p>The main treatment of cardiovascular diseases (CVDs) based on extracellular vesicle (EV) modification. Therapeutic molecules such as microRNA (miRNA) and proteins were loaded into EVs to treat myocardial injury in mouse models. EVs isolated from cells pretreated with the drugs has the effect of treating CVDs. EVs modified by membrane engineering and genetic engineering can better target and treat the damaged areas of the cardiac. EVs can be combined with different kinds of hydrogels to make therapeutic cardiac patches or cardiac scaffolds, which have therapeutic effects in mouse and pig models.</p></caption><graphic xlink:href="MCO2-4-e454-g001" position="anchor" id="jats-graphic-9"/></fig><sec id="mco2454-sec-0250"><label>4.1</label><title>EVs targeted delivery of therapeutic molecules for the treatment of CVDs</title><sec id="mco2454-sec-0260"><label>4.1.1</label><title>EVs modified with small biomolecules</title><p>EVs have the potential to serve as a natural carrier for delivering drugs, and their effectiveness can be enhanced by incorporating bioactive molecules (e.g., miRNAs, proteins, and synthetic molecules) and engineering modifications. In one study, combining MSC&#x02010;derived exosomes with the delivery of miR&#x02010;181a had a synergistic effect, using both the immunosuppressive properties of the miRNA and the targeted delivery capability of the MSC&#x02010;derived exosomes. Mice suffering from myocardial I/R injury showed significant improvements in cardiac function and reduced infarct size after receiving treatment with MSC&#x02010;derived exosomes loaded with miR&#x02010;181a.<xref rid="mco2454-bib-0161" ref-type="bibr">
<sup>161</sup>
</xref> In addition, studies have shown that miR&#x02010;101a has an anti&#x02010;fibrotic effect. MSC&#x02010;derived extracellular nanovesicles loaded with miR&#x02010;101a could be administered in a minimally invasive manner to promote recovery after heart infarction.<xref rid="mco2454-bib-0162" ref-type="bibr">
<sup>162</sup>
</xref> Additionally, exosomes derived from miR&#x02010;214 overexpressed MSCs greatly enhance the therapeutic effect of AMI by promoting cardiomyocyte survival and EC function.<xref rid="mco2454-bib-0163" ref-type="bibr">
<sup>163</sup>
</xref>
</p><p>In addition, other studies have isolated EVs with CD47&#x02010;modified membrane surfaces from MSCs overexpressing <italic toggle="yes">CD47</italic>. EVs loaded with exogenous miR&#x02010;21 had a good anti&#x02010;apoptotic effect in vitro and in vivo, which can relieve cardiac inflammation and be used to treat myocardial I/R injury.<xref rid="mco2454-bib-0164" ref-type="bibr">
<sup>164</sup>
</xref> Studies have shown that miR&#x02010;93&#x02010;5p expression has a cardioprotective effect after AMI. ADSC&#x02010;derived exosomes loaded with miR&#x02010;93&#x02010;5p mitigated myocardial damage caused by AMI by targeting autophagy&#x02010;related 7 (<italic toggle="yes">ATG7</italic>) and <italic toggle="yes">TLR4</italic> to inhibit autophagy and inflammatory responses.<xref rid="mco2454-bib-0165" ref-type="bibr">
<sup>165</sup>
</xref> In addition, TIMP metallopeptidase inhibitor 2 (TIMP2)&#x02010;modified exosomes from hUCMSCs enhanced the repair of MI in rats through the AKT/secreted frizzled&#x02010;related protein 2 (SFRP2) pathway, alleviating MI&#x02010;induced oxidative stress and extracellular matrix remodeling.<xref rid="mco2454-bib-0166" ref-type="bibr">
<sup>166</sup>
</xref> Moreover, by upregulating miR&#x02010;27b&#x02010;3p levels in exosomes derived from hypoxia&#x02010;deficient cardiac microvascular ECs, researchers could alleviate myocardial I/R injury in rats by inhibiting FOXO1/GSDMD signaling, reducing oxidative stress, and preventing pyrodeath.<xref rid="mco2454-bib-0167" ref-type="bibr">
<sup>167</sup>
</xref> Exosomes from cardiac fibroblasts overexpressing miR&#x02010;133a were also shown to inhibit myocardial pyrodeath in myocardial I/R injury, enhancing the therapeutic outcome of I/R injury.<xref rid="mco2454-bib-0168" ref-type="bibr">
<sup>168</sup>
</xref> Fibroblast exosomes overexpressing <italic toggle="yes">GATA4</italic> can also play a protective role in myocardial ischemic injury.<xref rid="mco2454-bib-0079" ref-type="bibr">
<sup>79</sup>
</xref> Furthermore, CDC&#x02010;derived EVs modified with &#x003b2;ARKct, a peptide inhibitor of G&#x02010;protein&#x02010;coupled receptor kinase 2 (<italic toggle="yes">GRK2</italic>), significantly protected against ischemic injury and improved cardiac function after MI and had HF&#x02010;preventive properties in a model of HF catecholamine toxicity.<xref rid="mco2454-bib-0169" ref-type="bibr">
<sup>169</sup>
</xref> Other studies have shown that genetically engineered EVs derived from HEK293T cells overexpressing miRNA&#x02010;21 can be used to treat MI and improve cardiac function.<xref rid="mco2454-bib-0170" ref-type="bibr">
<sup>170</sup>
</xref>
</p></sec><sec id="mco2454-sec-0270"><label>4.1.2</label><title>EVs loaded with medicines</title><p>Several studies have shown that some traditional Chinese medicines, such as Tongxinluo, Oridonin, and Irisin, have therapeutic effects on CVDs. Tongxinluo pretreated MSC&#x02010;derived exosomes carrying miR&#x02010;146a&#x02010;5p significantly promoted cardiac repair through a novel mechanism targeting the interleukin 1 receptor&#x02010;associated kinase 1 (IRAK1)/NF&#x02010;&#x003ba;B p65 pathway and have excellent clinical translation potential.<xref rid="mco2454-bib-0171" ref-type="bibr">
<sup>171</sup>
</xref> In addition, BMSC&#x02010;derived exosomes pretreated with Oridonin inhibited apoptosis by regulating autophagy activation, reducing myocardial I/R injury.<xref rid="mco2454-bib-0172" ref-type="bibr">
<sup>172</sup>
</xref> Exosomes secreted by Irisin&#x02010;pretreated BMSCs alleviated the effects of myocardial scorch death and oxidative stress on myocardial H/R injury.<xref rid="mco2454-bib-0173" ref-type="bibr">
<sup>173</sup>
</xref> Besides, MSCs&#x02010;derived EVs pretreated with Atorvastatin (ATV) promote macrophage polarization through the miR&#x02010;139&#x02010;3p/STAT1 pathway, significantly promoting cardiac repair after AMI.<xref rid="mco2454-bib-0174" ref-type="bibr">
<sup>174</sup>
</xref> It has also been demonstrated that exosomes obtained from MSCs pretreated with ATV may significantly improve the therapeutic efficacy of AMI by upregulating lncRNA H19 and promoting ECs function.<xref rid="mco2454-bib-0175" ref-type="bibr">
<sup>175</sup>
</xref> Moreover, Hemin&#x02010;pretreated MSC&#x02010;derived exosome has a protective effect on the infarcted heart, in which the exosomal miR&#x02010;183&#x02010;5p inhibits cardiomyocyte senescence by regulating the high mobility group box&#x02010;1 (HMGB1)/ERK pathway.<xref rid="mco2454-bib-0176" ref-type="bibr">
<sup>176</sup>
</xref>
</p></sec><sec id="mco2454-sec-0280"><label>4.1.3</label><title>Membrane&#x02010;modified EVs</title><p>One major challenge to the clinical application of EVs therapy is their low yield and poor homing efficiency. To improve the delivery efficiency of EVs to injured myocardium, a membrane fusion method was used to modify MSC&#x02010;derived EVs with monocyte simulators. Imitating the recruitment characteristics of monocytes after MI enhanced the targeting efficiency of the EVs to the injured myocardium and improved cardiac function and pathologic outcomes in a mouse model of MI.<xref rid="mco2454-bib-0177" ref-type="bibr">
<sup>177</sup>
</xref> In addition, immunomodulatory therapy has been identified as a promising approach for treating myocardial MI/R injury.</p><p>Studies have developed a new type of EV called platelet membrane&#x02010;modified EVs (P&#x02010;EVs), which use a membrane fusion method to mimic the binding affinity between platelets and monocytes and improve EVs targeting. In I/R myocardial injury mouse models, intravenous P&#x02010;EVs could be carried by circulating monocytes to the ischemic myocardium and release functional miRNAs into the cytoplasm, facilitating the reprogramming of inflammatory macrophages (M1 phenotype) into repair macrophages (M2 phenotype) to achieve cardiac repair by modulating the immune microenvironment.<xref rid="mco2454-bib-0178" ref-type="bibr">
<sup>178</sup>
</xref> In addition, studies have shown that hybridizing exosomes with platelet membranes enhanced their ability to target injured hearts and avoid being captured by macrophages. Hybridized exosomes had a cardiac targeting ability in MI injury mouse models, enhancing their combination and accumulation in damaged tissues.<xref rid="mco2454-bib-0179" ref-type="bibr">
<sup>179</sup>
</xref> Besides, an EV membrane anchoring platform called &#x0201c;cloaking&#x0201d; has also been described for directly embedding tissue&#x02010;specific antibodies or homing peptides into the EVs membrane surface in vitro to enhance their uptake by target cells. A modified glycerin&#x02013;phospholipid&#x02013;polyethylene glycol conjugate was added to CDC&#x02010;derived EVs by membrane engineering to target cardiac fibroblasts, myoblasts, and ischemic myocardium, showing good tissue targeting in animal models of CVDs.<xref rid="mco2454-bib-0180" ref-type="bibr">
<sup>180</sup>
</xref>
</p><p>Studies have used a targeting peptide (cardiac homing peptide) conjugated to cardiac stem cell&#x02010;derived exosomes to target infarcted hearts with intravenous exosomes in animal models of I/R injury, significantly improving cardiac function.<xref rid="mco2454-bib-0181" ref-type="bibr">
<sup>181</sup>
</xref> Other studies used CDCs to express an exosome membrane protein, lysosomal&#x02010;associated membrane protein 2 (Lamp2b), fused to a cardiomyocyte&#x02010;specific peptide (CMP). The engineered CDCs produced targeted exosomes that had the CMP on their surface. This modification increased exosome uptake by cardiomyocytes, reducing cardiomyocyte apoptosis and improving cardiac retention following intramuscular injection.<xref rid="mco2454-bib-0182" ref-type="bibr">
<sup>182</sup>
</xref> This approach may be a valid strategy for evaluating the efficacy of stem cell EVs and could help manage regenerative therapies in the clinic for ischemic heart disease. Studies have also shown that exosome expressing cardiac homing peptide (HHP) on the surface preferentially targets the heart and improves the therapeutic effect of CDCs&#x02010;exosomes on cardiac hypertrophy.<xref rid="mco2454-bib-0183" ref-type="bibr">
<sup>183</sup>
</xref> Moreover, the self&#x02010;assembly of a dry cell membrane&#x02010;camouflaged exosome&#x02010;mimicking nanocomplex has been reported. It recapitulates exosome function and targets ischemic cardiomyocytes to achieve efficient miRNA delivery, facilitating miRNA&#x02010;mediated myocardial repair.<xref rid="mco2454-bib-0184" ref-type="bibr">
<sup>184</sup>
</xref> Other studies combined several methods to genetically modify EVs, functionalize the EV surface with cardio&#x02010;targeting peptide (CTP), and further load Curcumin and miR&#x02010;144&#x02010;3p into CTP&#x02010;EVs, thus generating cardio&#x02010;targeting EV and improving the therapeutic effect of MI.<xref rid="mco2454-bib-0185" ref-type="bibr">
<sup>185</sup>
</xref>
</p></sec></sec><sec id="mco2454-sec-0290"><label>4.2</label><title>EVs combined with hydrogel for treating CVDs</title><p>In addition to the application of modified EVs, the application of EVs combined with biomaterials is also an exciting research direction. Bioengineering&#x02010;based therapies for CVDs often combine EVs with hydrogels. A system has been developed in which engineered hydrogel patches slowly release EVs secreted by iPSC&#x02010;derived cardiomyocytes to reduce arrhythmia load and myocardial apoptosis after infarction. The EVs are rich in cardio&#x02010;specific miRNAs known to regulate cardiomyocyte&#x02010;specific processes. Their prolonged delivery to the heart may contribute to understanding cardiac recovery mechanisms and treating cardiac injuries.<xref rid="mco2454-bib-0186" ref-type="bibr">
<sup>186</sup>
</xref> Another study applied shear thinning gel (STG) to deliver EVs derived from endothelial progenitor cells, which enhanced periinfarction angiogenesis and myocardial hemodynamics after delivery to ischemic myocardium, and STG greatly improved the efficiency and efficacy of EV&#x02010;mediated therapy for myocardium.<xref rid="mco2454-bib-0187" ref-type="bibr">
<sup>187</sup>
</xref>
</p><p>The short half&#x02010;life and rapid clearance of exosomes result in inadequate therapeutic doses for diseased areas. An injectable conductive hydrogel containing hUCMSC&#x02010;derived exosomes was developed to treat myocardial injury after I/R injury in MI. This system had a significant therapeutic effect on MI&#x02010;I/R and provided a promising therapeutic approach for damaged myocardial tissue.<xref rid="mco2454-bib-0188" ref-type="bibr">
<sup>188</sup>
</xref> A gelatin&#x02010;based biocompatible microneedle patch was prepared to load exosomes isolated from hUCMSCs containing miR&#x02010;29b mimics, which can relieve inflammation, reduce infarct size, inhibit fibrosis, and improve cardiac function.<xref rid="mco2454-bib-0189" ref-type="bibr">
<sup>189</sup>
</xref> Further studies were conducted to assess the effectiveness of tissue engineering techniques in delivering EVs secreted by porcine cardiac ADSCs (cATMSC&#x02010;EVs) in AMI models. They used acellular pericardial scaffolds filled with peptide hydrogels and cATMSC&#x02010;EVs purified by dimensional expulsion chromatography placed on the post&#x02010;infarction myocardium. Their results showed that EV administration enhanced cardiac function in the treated animals, indicating the potential of cATMSC&#x02010;EVs as a viable treatment option for MI.<xref rid="mco2454-bib-0190" ref-type="bibr">
<sup>190</sup>
</xref>
</p><p>Furthermore, secreted acidic cysteine&#x02010;rich glycoprotein (<italic toggle="yes">Sparc</italic>) overexpression in Tregs might help repair infarcted tissue after AMI. The study demonstrated that EVs from <italic toggle="yes">Sparc</italic>&#x02010;overexpressing Tregs combined with temporally responsive pH/H<sub>2</sub>O<sub>2</sub>/matrix metallopeptidase 9 (MMP9) hydrogel microspheres decreased myocardial injury and enhanced cardiac function.<xref rid="mco2454-bib-0191" ref-type="bibr">
<sup>191</sup>
</xref>
</p></sec></sec><sec id="mco2454-sec-0300"><label>5</label><title>DISCUSSION</title><p>Many risk factors accompany CVDs, which has a complex disease process and pathogenesis.<xref rid="mco2454-bib-0192" ref-type="bibr">
<sup>192</sup>
</xref> Being carried by EVs is an effective way for biomolecules to regulate myocardial cell apoptosis and survival through systemic circulation.<xref rid="mco2454-bib-0193" ref-type="bibr">
<sup>193</sup>
</xref> EVs can specifically induce significant changes in the pathological progression of CVDs and exert their influence by regulating gene expression. EVs derived from different cardiac or stem cells can promote or inhibit CVDs through different regulatory mechanisms. The quantity and composition of circulating EVs also serve as novel indicators of cardiovascular risk.<xref rid="mco2454-bib-0194" ref-type="bibr">
<sup>194</sup>
</xref> Exploring how EVs affect the progression of CVDs is crucial for developing effective cardiac protection strategies. This review provided an overview of the current understanding of the causes and management of CVDs related to EVs and explored the primary mechanisms involved in advancing these treatment approaches.</p><p>EVs represent the next generation of therapies with strong appeal as cell&#x02010;free drugs that overcome the major hurdles of cell therapy while also serving as a versatile platform.<xref rid="mco2454-bib-0195" ref-type="bibr">
<sup>195</sup>
</xref> The pathological process of CVDs is associated with extensive intercellular communication. The transfer of EVs between various cardiac cells plays a key role in the physiological pathology of CVDs.<xref rid="mco2454-bib-0196" ref-type="bibr">
<sup>196</sup>
</xref> Studies have shown that EVs from heart&#x02010;related cells are rapidly absorbed by heart tissue, and there is evidence that cells preferentially take up EVs from the same tissues.<xref rid="mco2454-bib-0197" ref-type="bibr">
<sup>197</sup>
</xref> Besides myocardial cells, macrophages, ECs, and fibroblasts are the primary recipients of EVs, and these cell types may mediate the cardioprotective effect.<xref rid="mco2454-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref> These heart&#x02010;related cell&#x02010;derived EVs may play an important role in treating CVDs.</p><p>In addition, stem cell&#x02010;derived EVs are another commonly used method for repairing CVDs. MSCs have anti&#x02010;inflammatory and regenerative functions, and most literature suggests that MSC&#x02010;derived EVs show protective activity in a variety of diseases.<xref rid="mco2454-bib-0198" ref-type="bibr">
<sup>198</sup>
</xref> MSCs can differentiate into bone cells, fat cells, and chondrocytes, which are considered suitable for heart damage repair. Many studies have shown that the secretions of MSCs, mainly EVs, have better therapeutic effects than the MSCs themselves.<xref rid="mco2454-bib-0199" ref-type="bibr">
<sup>199</sup>
</xref> EVs allow for easier quality control and better biosecurity. Therefore, MSC&#x02010;derived EVs are becoming a new therapeutic approach for treating CVDs.<xref rid="mco2454-bib-0200" ref-type="bibr">
<sup>200</sup>
</xref> Moreover, increasing evidence shows that EVs derived from ESCs or iPSCs have a promising application prospect in treating CVDs.</p><p>While EVs have shown encouraging outcomes in managing cardiac injury, certain issues remain to be resolved. The route, time, and location of EV injection into the heart also have a certain impact on the therapeutic effect of EVs. The application of EVs can be optimized by enhancing the targeting of EVs to the heart muscle. However, it is difficult to determine the specific amount of EVs administered in preclinical trials since it needs to be adjusted under different conditions and models.<xref rid="mco2454-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> In addition, certain challenges exist in isolating and characterizing EVs, necessitating further investigation into extraction techniques to enhance the quantity and quality of EVs obtained. Furthermore, different EV populations can be obtained by different separation methods, such as the ultrafast centrifugal or kit methods.<xref rid="mco2454-bib-0201" ref-type="bibr">
<sup>201</sup>
</xref> Whether these differences lead to inconsistent outcomes in EV treatment remains unclear. There is a need to establish uniform standards for EV extraction and quantity to better assess their application value.<xref rid="mco2454-bib-0202" ref-type="bibr">
<sup>202</sup>
</xref>
</p><p>The low application efficiency of EVs is the main obstacle to their clinical use. However, researchers are making progress in addressing these issues as well. Compared with directly extracted EVs, artificial EVs loaded with biomolecules can achieve better therapeutic effects at the genetic level and can also reverse the regulatory pathways leading to CVDs. Transgenic EVs have shown promising potential in treating myocardial injury. For example, overexpressing beneficial miRNAs related to myocardial damage (miR&#x02010;181a, miR&#x02010;27b&#x02010;3p, miR&#x02010;214, and miR&#x02010;133a) or loading EVs with exogenous molecules (miR&#x02010;93&#x02010;5p and miR&#x02010;21) showed better therapeutic effects than unmodified EVs. Moreover, previous studies have administered EVs via both intracoronary and intramyocardial injections. Intramyocardial administration is the more effective method, but its application in clinical settings is challenging.<xref rid="mco2454-bib-0203" ref-type="bibr">
<sup>203</sup>
</xref>
</p><p>In addition, most intravenous EVs are absorbed in the liver, necessitating a larger EV dose for treatment. Therefore, improving EV targeting to the myocardial injury area is crucial. Several studies have modified EVs using membrane fusion methods or the expression of CTPs conjugated on their surface, significantly overcoming the problem of poor targeting efficiency and enhancing EV accumulation in the injured myocardium.<xref rid="mco2454-bib-0204" ref-type="bibr">
<sup>204</sup>
</xref> Currently, studies are using synthetic biomimetic sEVs for targeted drug delivery to improve drug delivery efficiency, which may be based on EV treatment of CVDs and a promising research direction.<xref rid="mco2454-bib-0205" ref-type="bibr">
<sup>205</sup>
</xref>
</p><p>In addition, another approach is to optimize the delivery mode of EVs. Applying biomaterial hydrogels can significantly optimize EV retention, forming stable gel patches or scaffolds on the heart and improving treatment efficacy in promoting myocardial injury in animal models. In addition, using drug&#x02010;pretreated MSC&#x02010;derived EVs may also promote therapeutic efficacy. The EVs derived from MSCs pretreated with Tongxinluo, Oridonin, Irisin, Curcumin, ATV, and hemin had enhanced therapeutic effects on CVDs. Bioengineered EVs loaded with single or multiple biomolecules and drugs are gradually becoming the favored therapeutic approach for CVDs, with advantages such as low cytotoxicity, high specificity in targeting damaged tissues, and immune escape.<xref rid="mco2454-bib-0206" ref-type="bibr">
<sup>206</sup>
</xref> In conclusion, it is necessary to develop safer and more effective EV therapies for CVDs that can be applied clinically, increase the validation of EVs in animal models and clinical trials, and seek more promising research directions for treating CVDs.</p></sec><sec id="mco2454-sec-0310"><label>6</label><title>CONCLUSIONS</title><p>In vitro and in vivo studies have effectively demonstrated the enormous potential of EVs in cardiology. This review summarized the specific regulatory mechanisms of EVs in the pathogenesis and treatment of CVDs. It also illustrated the impact of heart and stem cell&#x02010;derived EVs on CVDs repair and cardiac function restoration in animal models. Bioengineering of EVs can further improve their targeting and better deliver therapeutic molecules, overcoming the limitations of applying EVs. This review provided comprehensive insight into the pathogenesis and treatment of CVDs using EVs, which can provide a specific foundation for inspiring more valuable research directions.</p></sec><sec id="mco2454-sec-0320"><title>AUTHOR CONTRIBUTIONS</title><p>
<italic toggle="yes">Conceptualization</italic>: Q.L., G.G., and D.W. <italic toggle="yes">Investigation</italic>: Q.L. and D.W. <italic toggle="yes">Project administration</italic>: G.G. and D.W. <italic toggle="yes">Resources</italic>: D.W. <italic toggle="yes">Supervision</italic>: G.G. and D.W. <italic toggle="yes">Visualization and writing&#x02014;original draft</italic>: Q.L. <italic toggle="yes">Writing&#x02014;review and editing</italic>: Q.L., Q.F., H.Z., C.L., X.S., C.M., L.S., G.G., and D.W. All authors have read and approved the final manuscript.</p></sec><sec sec-type="COI-statement" id="mco2454-sec-0340"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare they have no conflicts of interest.</p></sec><sec id="mco2454-sec-0370"><title>ETHICS STATEMENT</title><p>Not applicable.</p></sec></body><back><ack id="mco2454-sec-0330"><title>ACKNOWLEDGMENTS</title><p>The authors appreciate all the participants for their contributions. This work was supported by the Jilin Province University Key Laboratory Scientific Research Program under grant (2019) no. 004, the Jilin Education Department Program under grant JJKH20230259KJ, the Jilin Province Development and Reform Commission Program under grant 2023C028&#x02010;6, and the Jilin Scientific and Technological Development Program under grant 20210101010JC, 20210203080SF, and 20220505033ZP.</p></ack><sec sec-type="data-availability" id="mco2454-sec-0360"><title>DATA AVAILABILITY STATEMENT</title><p>The data that support the findings of this study are available in the review.</p></sec><ref-list id="mco2454-bibl-0001"><title>REFERENCES</title><ref id="mco2454-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="mco2454-cit-0001">
<string-name>
<surname>Virani</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Alonso</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Aparicio</surname>
<given-names>HJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Heart disease and stroke statistics&#x02014;2021 update: a report from the American Heart Association</article-title>. <source>Circulation</source>. <year>2021</year>;<volume>143</volume>(<issue>8</issue>):<fpage>e254</fpage>&#x02010;<lpage>e743</lpage>.<pub-id pub-id-type="pmid">33501848</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="mco2454-cit-0002">
<string-name>
<surname>Roth</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Abajobir</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015</article-title>. <source>J Am Coll Cardiol</source>. <year>2017</year>;<volume>70</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02010;<lpage>25</lpage>.<pub-id pub-id-type="pmid">28527533</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="mco2454-cit-0003">
<string-name>
<surname>Alam</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Maliken</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>SM</given-names>
</string-name>, et&#x000a0;al. <article-title>Cardiac remodeling and repair: recent approaches, advancements, and future perspective</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<volume>22</volume>(<issue>23</issue>):<elocation-id>13104</elocation-id>.<pub-id pub-id-type="pmid">34884909</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="mco2454-cit-0004">
<string-name>
<surname>Rockey</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Bell</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Fibrosis&#x02014;a common pathway to organ injury and failure</article-title>. <source>N Engl J Med</source>. <year>2015</year>;<volume>373</volume>(<issue>1</issue>):<fpage>96</fpage>.</mixed-citation></ref><ref id="mco2454-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="mco2454-cit-0005">
<string-name>
<surname>Kim</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Mahmoudi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ge</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium</article-title>. <source>Circ Res</source>. <year>2015</year>;<volume>116</volume>(<issue>7</issue>):<fpage>e40</fpage>&#x02010;<lpage>e50</lpage>.<pub-id pub-id-type="pmid">25654979</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="mco2454-cit-0006">
<string-name>
<surname>Passier</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>van Laake</surname>
<given-names>LW</given-names>
</string-name>, <string-name>
<surname>Mummery</surname>
<given-names>CL</given-names>
</string-name>. <article-title>Stem&#x02010;cell&#x02010;based therapy and lessons from the heart</article-title>. <source>Nature</source>. <year>2008</year>;<volume>453</volume>(<issue>7193</issue>):<fpage>322</fpage>&#x02010;<lpage>329</lpage>.<pub-id pub-id-type="pmid">18480813</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="mco2454-cit-0007">
<string-name>
<surname>Deatherage</surname>
<given-names>BL</given-names>
</string-name>, <string-name>
<surname>Cookson</surname>
<given-names>BT</given-names>
</string-name>. <article-title>Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life</article-title>. <source>Infect Immun</source>. <year>2012</year>;<volume>80</volume>(<issue>6</issue>):<fpage>1948</fpage>&#x02010;<lpage>1957</lpage>.<pub-id pub-id-type="pmid">22409932</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="mco2454-cit-0008">
<string-name>
<surname>Kalluri</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>LeBleu</surname>
<given-names>VS</given-names>
</string-name>. <article-title>The biology, function, and biomedical applications of exosomes</article-title>. <source>Science</source>. <year>2020</year>;<volume>367</volume>(<issue>6478</issue>):<elocation-id>eaau6977</elocation-id>.<pub-id pub-id-type="pmid">32029601</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="mco2454-cit-0009">
<string-name>
<surname>Gu</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>YW</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>LJ</given-names>
</string-name>, et&#x000a0;al. <article-title>The multifaceted involvement of exosomes in tumor progression: induction and inhibition</article-title>. <source>Medcomm</source>. <year>2021</year>;<volume>2</volume>(<issue>3</issue>):<fpage>297</fpage>&#x02010;<lpage>314</lpage>.<pub-id pub-id-type="pmid">34766148</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="mco2454-cit-0010">
<string-name>
<surname>Thery</surname>
<given-names>C</given-names>
</string-name>. <article-title>Exosomes: secreted vesicles and intercellular communications</article-title>. <source>F1000 Biol Rep</source>. <year>2011</year>;<volume>3</volume>:<fpage>15</fpage>.<pub-id pub-id-type="pmid">21876726</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="mco2454-cit-0011">
<string-name>
<surname>Bobrie</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Colombo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Raposo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Thery</surname>
<given-names>C</given-names>
</string-name>. <article-title>Exosome secretion: molecular mechanisms and roles in immune responses</article-title>. <source>Traffic</source>. <year>2011</year>;<volume>12</volume>(<issue>12</issue>):<fpage>1659</fpage>&#x02010;<lpage>1668</lpage>.<pub-id pub-id-type="pmid">21645191</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="mco2454-cit-0012">
<string-name>
<surname>Zheng</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Huo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>The role of exosomes and exosomal microRNA in cardiovascular disease</article-title>. <source>Front Cell Dev Biol</source>. <year>2020</year>;<volume>8</volume>:<elocation-id>616161</elocation-id>.<pub-id pub-id-type="pmid">33511124</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="mco2454-cit-0013">
<string-name>
<surname>Frangogiannis</surname>
<given-names>NG</given-names>
</string-name>. <article-title>Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities</article-title>. <source>Mol Aspects Med</source>. <year>2019</year>;<volume>65</volume>:<fpage>70</fpage>&#x02010;<lpage>99</lpage>.<pub-id pub-id-type="pmid">30056242</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="mco2454-cit-0014">
<string-name>
<surname>Shah</surname>
<given-names>RV</given-names>
</string-name>, <string-name>
<surname>Mitchell</surname>
<given-names>RN</given-names>
</string-name>. <article-title>The role of stem cells in the response to myocardial and vascular wall injury</article-title>. <source>Cardiovasc Pathol</source>. <year>2005</year>;<volume>14</volume>(<issue>5</issue>):<fpage>225</fpage>&#x02010;<lpage>231</lpage>.<pub-id pub-id-type="pmid">16168894</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="mco2454-cit-0015">
<string-name>
<surname>de Abreu</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Fernandes</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Martins</surname>
<given-names>PAD</given-names>
</string-name>, <string-name>
<surname>Sahoo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Emanueli</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ferreira</surname>
<given-names>L</given-names>
</string-name>. <article-title>Native and bioengineered extracellular vesicles for cardiovascular therapeutics</article-title>. <source>Nat Rev Cardiol</source>. <year>2020</year>;<volume>17</volume>(<issue>11</issue>):<fpage>685</fpage>&#x02010;<lpage>697</lpage>.<pub-id pub-id-type="pmid">32483304</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="mco2454-cit-0016">
<string-name>
<surname>Tang</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>XL</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>ZL</given-names>
</string-name>, et&#x000a0;al. <article-title>Injection&#x02010;free delivery of MSC&#x02010;derived extracellular vesicles for myocardial infarction therapeutics</article-title>. <source>Adv Healthcare Mater</source>. <year>2022</year>;<volume>11</volume>(<issue>5</issue>):<elocation-id>e2100312</elocation-id>.</mixed-citation></ref><ref id="mco2454-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="mco2454-cit-0017">
<string-name>
<surname>Ali</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pham</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wolfram</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pham</surname>
<given-names>S</given-names>
</string-name>. <article-title>Extracellular vesicles for treatment of solid organ ischemia&#x02013;reperfusion injury</article-title>. <source>Am J Transplant</source>. <year>2020</year>;<volume>20</volume>(<issue>12</issue>):<fpage>3294</fpage>&#x02010;<lpage>3307</lpage>.<pub-id pub-id-type="pmid">32594616</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="mco2454-cit-0018">
<string-name>
<surname>Tkach</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Thery</surname>
<given-names>C</given-names>
</string-name>. <article-title>Communication by extracellular vesicles: where we are and where we need to go</article-title>. <source>Cell</source>. <year>2016</year>;<volume>164</volume>(<issue>6</issue>):<fpage>1226</fpage>&#x02010;<lpage>1232</lpage>.<pub-id pub-id-type="pmid">26967288</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="mco2454-cit-0019">
<string-name>
<surname>Penna</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Femmino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Alloatti</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Brizzi</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Angelone</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pagliaro</surname>
<given-names>P</given-names>
</string-name>. <article-title>Extracellular vesicles in comorbidities associated with ischaemic heart disease: focus on sex, an overlooked factor</article-title>. <source>J Clin Med</source>. <year>2021</year>;<volume>10</volume>(<issue>2</issue>):<fpage>327</fpage>.<pub-id pub-id-type="pmid">33477341</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="mco2454-cit-0020">
<string-name>
<surname>Bang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Batkai</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dangwal</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Cardiac fibroblast&#x02010;derived microRNA passenger strand&#x02010;enriched exosomes mediate cardiomyocyte hypertrophy</article-title>. <source>J Clin Invest</source>. <year>2014</year>;<volume>124</volume>(<issue>5</issue>):<fpage>2136</fpage>&#x02010;<lpage>2146</lpage>.<pub-id pub-id-type="pmid">24743145</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="mco2454-cit-0021">
<string-name>
<surname>Yeh</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Sidney</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chandra</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sorel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Selby</surname>
<given-names>JV</given-names>
</string-name>, <string-name>
<surname>Go</surname>
<given-names>AS</given-names>
</string-name>. <article-title>Population trends in the incidence and outcomes of acute myocardial infarction</article-title>. <source>N Engl J Med</source>. <year>2010</year>;<volume>362</volume>(<issue>23</issue>):<fpage>2155</fpage>&#x02010;<lpage>2165</lpage>.<pub-id pub-id-type="pmid">20558366</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="mco2454-cit-0022">
<string-name>
<surname>Frank</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bonney</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bonney</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Weitzel</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Koeppen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Eckle</surname>
<given-names>T</given-names>
</string-name>. <article-title>Myocardial ischemia reperfusion injury: from basic science to clinical bedside</article-title>. <source>Semin Cardiothorac Vasc Anesth</source>. <year>2012</year>;<volume>16</volume>(<issue>3</issue>):<fpage>123</fpage>&#x02010;<lpage>132</lpage>.<pub-id pub-id-type="pmid">22368166</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="mco2454-cit-0023">
<string-name>
<surname>Hausenloy</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Yellon</surname>
<given-names>DM</given-names>
</string-name>. <article-title>Myocardial ischemia&#x02013;reperfusion injury: a neglected therapeutic target</article-title>. <source>J Clin Invest</source>. <year>2013</year>;<volume>123</volume>(<issue>1</issue>):<fpage>92</fpage>&#x02010;<lpage>100</lpage>.<pub-id pub-id-type="pmid">23281415</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="mco2454-cit-0024">
<string-name>
<surname>Silva</surname>
<given-names>JCQE</given-names>
</string-name>, <string-name>
<surname>Coelho</surname>
<given-names>OR</given-names>
</string-name>, <string-name>
<surname>Andrade</surname>
<given-names>JM</given-names>
</string-name>, et&#x000a0;al. <article-title>Peri&#x02010;infarct zone characterized by cardiac magnetic resonance imaging is directly associated with the inflammatory activity during acute phase myocardial infarction</article-title>. <source>Inflammation</source>. <year>2014</year>;<volume>37</volume>(<issue>3</issue>):<fpage>678</fpage>&#x02010;<lpage>685</lpage>.<pub-id pub-id-type="pmid">24282109</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="mco2454-cit-0025">
<string-name>
<surname>Fan</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Tao</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Dectin&#x02010;1 contributes to myocardial ischemia/reperfusion injury by regulating macrophage polarization and neutrophil infiltration</article-title>. <source>Circulation</source>. <year>2019</year>;<volume>139</volume>(<issue>5</issue>):<fpage>663</fpage>&#x02010;<lpage>678</lpage>.<pub-id pub-id-type="pmid">30586706</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="mco2454-cit-0026">
<string-name>
<surname>Ge</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Myocardial ischemia&#x02013;reperfusion induced cardiac extracellular vesicles harbour proinflammatory features and aggravate heart injury</article-title>. <source>J Extracell Vesicles</source>. <year>2021</year>;<volume>10</volume>(<issue>4</issue>):<elocation-id>e12072</elocation-id>.<pub-id pub-id-type="pmid">33664937</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="mco2454-cit-0027">
<string-name>
<surname>Xia</surname>
<given-names>WZ</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>HB</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>DD</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>M</given-names>
</string-name>. <article-title>PD&#x02010;1 inhibitor inducing exosomal miR&#x02010;34a&#x02010;5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor&#x02010;related cardiac dysfunction</article-title>. <source>J Immunother Cancer</source>. <year>2020</year>;<volume>8</volume>(<issue>2</issue>):<elocation-id>e001293</elocation-id>.<pub-id pub-id-type="pmid">33115945</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="mco2454-cit-0028">
<string-name>
<surname>Liu</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>M1&#x02010;like macrophage&#x02010;derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment</article-title>. <source>Basic Res Cardiol</source>. <year>2020</year>;<volume>115</volume>(<issue>2</issue>):<fpage>22</fpage>.<pub-id pub-id-type="pmid">32112145</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="mco2454-cit-0029">
<string-name>
<surname>Wang</surname>
<given-names>CX</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>LX</given-names>
</string-name>, et&#x000a0;al. <article-title>Macrophage&#x02010;derived mir&#x02010;155&#x02010;containing exosomes suppress fibroblast proliferation and promote fibroblast inflammation during cardiac injury</article-title>. <source>Mol Ther</source>. <year>2017</year>;<volume>25</volume>(<issue>1</issue>):<fpage>192</fpage>&#x02010;<lpage>204</lpage>.<pub-id pub-id-type="pmid">28129114</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="mco2454-cit-0030">
<string-name>
<surname>Ma</surname>
<given-names>YG</given-names>
</string-name>. <article-title>Role of neutrophils in cardiac injury and repair following myocardial infarction</article-title>. <source>Cells</source>. <year>2021</year>;<volume>10</volume>(<issue>7</issue>):<fpage>1676</fpage>.<pub-id pub-id-type="pmid">34359844</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="mco2454-cit-0031">
<string-name>
<surname>Ge</surname>
<given-names>XY</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>QS</given-names>
</string-name>, <string-name>
<surname>Zhuang</surname>
<given-names>RL</given-names>
</string-name>, et&#x000a0;al. <article-title>Circular RNA expression alterations in extracellular vesicles isolated from murine heart post ischemia/reperfusion injury</article-title>. <source>Int J Cardiol</source>. <year>2019</year>;<volume>296</volume>:<fpage>136</fpage>&#x02010;<lpage>140</lpage>.<pub-id pub-id-type="pmid">31466885</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="mco2454-cit-0032">
<string-name>
<surname>Hu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>The harsh microenvironment in infarcted heart accelerates transplanted bone marrow mesenchymal stem cells injury: the role of injured cardiomyocytes&#x02010;derived exosomes</article-title>. <source>Cell Death Dis</source>. <year>2018</year>;<volume>9</volume>(<issue>3</issue>):<fpage>357</fpage>.<pub-id pub-id-type="pmid">29500342</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="mco2454-cit-0033">
<string-name>
<surname>Sun</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mang</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicle&#x02010;packaged mitochondrial disturbing miRNA exacerbates cardiac injury during acute myocardial infarction</article-title>. <source>Clin Transl Med</source>. <year>2022</year>;<volume>12</volume>(<issue>4</issue>):<elocation-id>e779</elocation-id>.<pub-id pub-id-type="pmid">35452193</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="mco2454-cit-0034">
<string-name>
<surname>Hu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>L</given-names>
</string-name>. <article-title>MicroRNA&#x02010;155&#x02010;5p in serum derived&#x02010;exosomes promotes ischaemia&#x02010;reperfusion injury by reducing CypD ubiquitination by NEDD4</article-title>. <source>ESC Heart Fail</source>. <year>2023</year>;<volume>10</volume>(<issue>2</issue>):<fpage>1144</fpage>&#x02010;<lpage>1157</lpage>.<pub-id pub-id-type="pmid">36631006</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="mco2454-cit-0035">
<string-name>
<surname>Eudailey</surname>
<given-names>KW</given-names>
</string-name>, <string-name>
<surname>Pat</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Oh</surname>
<given-names>JY</given-names>
</string-name>, et&#x000a0;al. <article-title>Plasma exosome hemoglobin released during surgery is associated with cardiac injury in animal model</article-title>. <source>Ann Thorac Surg</source>. <year>2022</year>;<volume>116</volume>(<issue>4</issue>):<fpage>834</fpage>&#x02010;<lpage>843</lpage>.<pub-id pub-id-type="pmid">35398036</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="mco2454-cit-0036">
<string-name>
<surname>Kornej</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Borschel</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Benjamin</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schnabel</surname>
<given-names>RB</given-names>
</string-name>. <article-title>Epidemiology of atrial fibrillation in the 21st century novel methods and new insights</article-title>. <source>Circ Res</source>. <year>2020</year>;<volume>127</volume>(<issue>1</issue>):<fpage>4</fpage>&#x02010;<lpage>20</lpage>.<pub-id pub-id-type="pmid">32716709</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="mco2454-cit-0037">
<string-name>
<surname>Shaihov&#x02010;Teper</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Ram</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ballan</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles from epicardial fat facilitate atrial fibrillation</article-title>. <source>Circulation</source>. <year>2021</year>;<volume>143</volume>(<issue>25</issue>):<fpage>2475</fpage>&#x02010;<lpage>2493</lpage>.<pub-id pub-id-type="pmid">33793321</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="mco2454-cit-0038">
<string-name>
<surname>Chen</surname>
<given-names>YW</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>XJ</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>HY</given-names>
</string-name>, et&#x000a0;al. <article-title>Serum extracellular vesicles containing MIAT induces atrial fibrosis, inflammation and oxidative stress to promote atrial remodeling and atrial fibrillation via blockade of miR&#x02010;485&#x02010;5p&#x02010;mediated CXCL10 inhibition</article-title>. <source>Clin Transl Med</source>. <year>2021</year>;<volume>11</volume>(<issue>8</issue>):<elocation-id>e482</elocation-id>.<pub-id pub-id-type="pmid">34459123</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="mco2454-cit-0039">
<string-name>
<surname>Falk</surname>
<given-names>E</given-names>
</string-name>. <article-title>Pathogenesis of atherosclerosis</article-title>. <source>J Am Coll Cardiol</source>. <year>2006</year>;<volume>47</volume>(<issue>8</issue>):<fpage>C7</fpage>&#x02010;<lpage>C12</lpage>.<pub-id pub-id-type="pmid">16631513</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="mco2454-cit-0040">
<string-name>
<surname>Nguyen</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Karunakaran</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Geoffrion</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles secreted by atherogenic macrophages transfer microRNA to inhibit cell migration</article-title>. <source>Arterioscl Throm Vas</source>. <year>2018</year>;<volume>38</volume>(<issue>1</issue>):<fpage>49</fpage>&#x02010;<lpage>63</lpage>.</mixed-citation></ref><ref id="mco2454-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="mco2454-cit-0041">
<string-name>
<surname>Peng</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles carrying proinflammatory factors may spread atherosclerosis to remote locations</article-title>. <source>Cell Mol Life Sci</source>. <year>2022</year>;<volume>79</volume>(<issue>8</issue>):<fpage>430</fpage>.<pub-id pub-id-type="pmid">35851433</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="mco2454-cit-0042">
<string-name>
<surname>Oggero</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>de Gaetano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Marcone</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivity</article-title>. <source>J Extracell Vesicles</source>. <year>2021</year>;<volume>10</volume>(<issue>6</issue>):<elocation-id>12084</elocation-id>.<pub-id pub-id-type="pmid">33936566</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="mco2454-cit-0043">
<string-name>
<surname>Zhou</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Application of exosomes as liquid biopsy in clinical diagnosis</article-title>. <source>Signal Transduct Tar</source>. <year>2020</year>;<volume>5</volume>(<issue>1</issue>):<fpage>144</fpage>.</mixed-citation></ref><ref id="mco2454-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="mco2454-cit-0044">
<string-name>
<surname>Cheng</surname>
<given-names>HL</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Kuo</surname>
<given-names>WC</given-names>
</string-name>, et&#x000a0;al. <article-title>Detecting miRNA biomarkers from extracellular vesicles for cardiovascular disease with a microfluidic system</article-title>. <source>Lab Chip</source>. <year>2018</year>;<volume>18</volume>(<issue>19</issue>):<fpage>2917</fpage>&#x02010;<lpage>2925</lpage>.<pub-id pub-id-type="pmid">30118128</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="mco2454-cit-0045">
<string-name>
<surname>Carrozzo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Casieri</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Di Silvestre</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Plasma exosomes characterization reveals a perioperative protein signature in older patients undergoing different types of on&#x02010;pump cardiac surgery</article-title>. <source>Geroscience</source>. <year>2021</year>;<volume>43</volume>(<issue>2</issue>):<fpage>773</fpage>&#x02010;<lpage>789</lpage>.<pub-id pub-id-type="pmid">32691393</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="mco2454-cit-0046">
<string-name>
<surname>Sahoo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Losordo</surname>
<given-names>DW</given-names>
</string-name>. <article-title>Exosomes and cardiac repair after myocardial infarction</article-title>. <source>Circ Res</source>. <year>2014</year>;<volume>114</volume>(<issue>2</issue>):<fpage>333</fpage>&#x02010;<lpage>344</lpage>.<pub-id pub-id-type="pmid">24436429</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="mco2454-cit-0047">
<string-name>
<surname>Deddens</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Vrijsen</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Colijn</surname>
<given-names>JM</given-names>
</string-name>, et&#x000a0;al. <article-title>Circulating extracellular vesicles contain miRNAs and are released as early biomarkers for cardiac injury</article-title>. <source>J Cardiovasc Transl</source>. <year>2016</year>;<volume>9</volume>(<issue>4</issue>):<fpage>291</fpage>&#x02010;<lpage>301</lpage>.</mixed-citation></ref><ref id="mco2454-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="mco2454-cit-0048">
<string-name>
<surname>Cheng</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>XB</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>A translational study of urine miRNAs in acute myocardial infarction</article-title>. <source>J Mol Cell Cardiol</source>. <year>2012</year>;<volume>53</volume>(<issue>5</issue>):<fpage>668</fpage>&#x02010;<lpage>676</lpage>.<pub-id pub-id-type="pmid">22921780</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="mco2454-cit-0049">
<string-name>
<surname>Cheow</surname>
<given-names>ESH</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>CN</given-names>
</string-name>, <string-name>
<surname>de Kleijn</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sorokin</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Sze</surname>
<given-names>SK</given-names>
</string-name>. <article-title>Plasma&#x02010;derived extracellular vesicles contain predictive biomarkers and potential therapeutic targets for myocardial ischemic (MI) injury</article-title>. <source>Mol Cell Proteomics</source>. <year>2016</year>;<volume>15</volume>(<issue>8</issue>):<fpage>2628</fpage>&#x02010;<lpage>2640</lpage>.<pub-id pub-id-type="pmid">27234505</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="mco2454-cit-0050">
<string-name>
<surname>Yarana</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Carroll</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles released by cardiomyocytes in a doxorubicin&#x02010;induced cardiac injury mouse model contain protein biomarkers of early cardiac injury</article-title>. <source>Free Radical Bio Med</source>. <year>2017</year>;<volume>112</volume>:<fpage>125</fpage>&#x02010;<lpage>126</lpage>.</mixed-citation></ref><ref id="mco2454-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="mco2454-cit-0051">
<string-name>
<surname>Kemp</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Conte</surname>
<given-names>JV</given-names>
</string-name>. <article-title>The pathophysiology of heart failure</article-title>. <source>Cardiovasc Pathol</source>. <year>2012</year>;<volume>21</volume>(<issue>5</issue>):<fpage>365</fpage>&#x02010;<lpage>371</lpage>.<pub-id pub-id-type="pmid">22227365</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="mco2454-cit-0052">
<string-name>
<surname>Matan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mobarrez</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lofstrom</surname>
<given-names>U</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles in heart failure&#x02014;a study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting</article-title>. <source>Front Cardiovasc Med</source>. <year>2022</year>;<volume>9</volume>:<elocation-id>952974</elocation-id>.<pub-id pub-id-type="pmid">36330003</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="mco2454-cit-0053">
<string-name>
<surname>Hegyesi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pallinger</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mecsei</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Circulating cardiomyocyte&#x02010;derived extracellular vesicles reflect cardiac injury during systemic inflammatory response syndrome in mice</article-title>. <source>Cell Mol Life Sci</source>. <year>2022</year>;<volume>79</volume>(<issue>2</issue>):<fpage>84</fpage>.<pub-id pub-id-type="pmid">35059851</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="mco2454-cit-0054">
<string-name>
<surname>Siwaponanan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kaewkumdee</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Phromawan</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Increased expression of six&#x02010;large extracellular vesicle&#x02010;derived miRNAs signature for nonvalvular atrial fibrillation</article-title>. <source>J Transl Med</source>. <year>2022</year>;<volume>20</volume>(<issue>1</issue>):<fpage>4</fpage>.<pub-id pub-id-type="pmid">34980172</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="mco2454-cit-0055">
<string-name>
<surname>Manole</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Cismasiu</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Gherghiceanu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Popescu</surname>
<given-names>LM</given-names>
</string-name>. <article-title>Experimental acute myocardial infarction: telocytes involvement in neo&#x02010;angiogenesis</article-title>. <source>J Cell Mol Med</source>. <year>2011</year>;<volume>15</volume>(<issue>11</issue>):<fpage>2284</fpage>&#x02010;<lpage>2296</lpage>.<pub-id pub-id-type="pmid">21895968</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="mco2454-cit-0056">
<string-name>
<surname>Akbar</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Azzimato</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Choudhury</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Aouadi</surname>
<given-names>M</given-names>
</string-name>. <article-title>Extracellular vesicles in metabolic disease</article-title>. <source>Diabetologia</source>. <year>2019</year>;<volume>62</volume>(<issue>12</issue>):<fpage>2179</fpage>&#x02010;<lpage>2187</lpage>.<pub-id pub-id-type="pmid">31690986</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="mco2454-cit-0057">
<string-name>
<surname>Femmino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Penna</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Margarita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Comita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Brizzi</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Pagliaro</surname>
<given-names>P</given-names>
</string-name>. <article-title>Extracellular vesicles and cardiovascular system: biomarkers and cardioprotective effectors</article-title>. <source>Vascul Pharmacol</source>. <year>2020</year>;<volume>135</volume>:<elocation-id>106790</elocation-id>.<pub-id pub-id-type="pmid">32861822</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="mco2454-cit-0058">
<string-name>
<surname>Hu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>A large&#x02010;scale investigation of hypoxia&#x02010;preconditioned allogeneic mesenchymal stem cells for myocardial repair in nonhuman primates: paracrine activity without remuscularization</article-title>. <source>Circ Res</source>. <year>2016</year>;<volume>118</volume>(<issue>6</issue>):<fpage>970</fpage>&#x02010;<lpage>983</lpage>.<pub-id pub-id-type="pmid">26838793</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="mco2454-cit-0059">
<string-name>
<surname>Mu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>XL</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Intracoronary transplantation of mesenchymal stem cells with overexpressed integrin&#x02010;linked kinase improves cardiac function in porcine myocardial infarction</article-title>. <source>Sci Rep</source>. <year>2016</year>;<volume>6</volume>:<elocation-id>19155</elocation-id>.<pub-id pub-id-type="pmid">26750752</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="mco2454-cit-0060">
<string-name>
<surname>van Balkom</surname>
<given-names>BWM</given-names>
</string-name>, <string-name>
<surname>de Jong</surname>
<given-names>OG</given-names>
</string-name>, <string-name>
<surname>Smits</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Endothelial cells require miR&#x02010;214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells</article-title>. <source>Blood</source>. <year>2013</year>;<volume>121</volume>(<issue>19</issue>):<fpage>3997</fpage>&#x02010;<lpage>4006</lpage>.<pub-id pub-id-type="pmid">23532734</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="mco2454-cit-0061">
<string-name>
<surname>Loyer</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zlatanova</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Devue</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Intra&#x02010;cardiac release of extracellular vesicles shapes inflammation following myocardial infarction</article-title>. <source>Circ Res</source>. <year>2018</year>;<volume>123</volume>(<issue>1</issue>):<fpage>100</fpage>&#x02010;<lpage>106</lpage>.<pub-id pub-id-type="pmid">29592957</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="mco2454-cit-0062">
<string-name>
<surname>Beez</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Haag</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Van Linthout</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sittinger</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Seifert</surname>
<given-names>M</given-names>
</string-name>. <article-title>Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes</article-title>. <source>J Nanobiotechnol</source>. <year>2019</year>;<volume>17</volume>:<fpage>72</fpage>.</mixed-citation></ref><ref id="mco2454-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="mco2454-cit-0063">
<string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>X</given-names>
</string-name>. <article-title>Exosomal transfer of miR&#x02010;30a between cardiomyocytes regulates autophagy after hypoxia</article-title>. <source>J Mol Med</source>. <year>2016</year>;<volume>94</volume>(<issue>6</issue>):<fpage>711</fpage>&#x02010;<lpage>724</lpage>.<pub-id pub-id-type="pmid">26857375</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="mco2454-cit-0064">
<string-name>
<surname>Chen</surname>
<given-names>GC</given-names>
</string-name>, <string-name>
<surname>Yue</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>MX</given-names>
</string-name>, <string-name>
<surname>Ruan</surname>
<given-names>ZB</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>L</given-names>
</string-name>. <article-title>The exosomal lncRNA KLF3&#x02010;AS1 from ischemic cardiomyocytes mediates IGF&#x02010;1 secretion by MSCs to rescue myocardial ischemia&#x02013;reperfusion injury</article-title>. <source>Front Cardiovasc Med</source>. <year>2021</year>;<volume>8</volume>:<elocation-id>671610</elocation-id>.<pub-id pub-id-type="pmid">34621793</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="mco2454-cit-0065">
<string-name>
<surname>Cheng</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>XQ</given-names>
</string-name>, et&#x000a0;al. <article-title>Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>:<fpage>959</fpage>.<pub-id pub-id-type="pmid">30814518</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="mco2454-cit-0066">
<string-name>
<surname>Davidson</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Riquelme</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Vicencio</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Lavandero</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yellon</surname>
<given-names>DM</given-names>
</string-name>. <article-title>Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>:<elocation-id>15885</elocation-id>.<pub-id pub-id-type="pmid">30367147</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="mco2454-cit-0067">
<string-name>
<surname>Zheng</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wen</surname>
<given-names>F</given-names>
</string-name>. <article-title>microRNA&#x02010;129 overexpression in endothelial cell&#x02010;derived extracellular vesicle influences inflammatory response caused by myocardial ischemia/reperfusion injury</article-title>. <source>Cell Biol Int</source>. <year>2021</year>;<volume>45</volume>(<issue>8</issue>):<fpage>1743</fpage>&#x02010;<lpage>1756</lpage>.<pub-id pub-id-type="pmid">33851774</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="mco2454-cit-0068">
<string-name>
<surname>Yadid</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lind</surname>
<given-names>JU</given-names>
</string-name>, <string-name>
<surname>Ardona</surname>
<given-names>HAM</given-names>
</string-name>, et&#x000a0;al. <article-title>Endothelial extracellular vesicles contain protective proteins and rescue ischemia&#x02013;reperfusion injury in a human heart&#x02010;on&#x02010;chip</article-title>. <source>Sci Transl Med</source>. <year>2020</year>;<volume>12</volume>(<issue>565</issue>):<elocation-id>eaax8005</elocation-id>.<pub-id pub-id-type="pmid">33055246</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="mco2454-cit-0069">
<string-name>
<surname>Su</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Lv</surname>
<given-names>XW</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>YL</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomal LINC00174 derived from vascular endothelial cells attenuates myocardial I/R injury via p53&#x02010;mediated autophagy and apoptosis</article-title>. <source>Mol Ther Nucl Acids</source>. <year>2021</year>;<volume>23</volume>:<fpage>1304</fpage>&#x02010;<lpage>1322</lpage>.</mixed-citation></ref><ref id="mco2454-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="mco2454-cit-0070">
<string-name>
<surname>Gollmann&#x02010;Tepekoylu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Polzl</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Graber</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>miR&#x02010;19a&#x02010;3p containing exosomes improve function of ischaemic myocardium upon shock wave therapy</article-title>. <source>Cardiovasc Res</source>. <year>2020</year>;<volume>116</volume>(<issue>6</issue>):<fpage>1226</fpage>&#x02010;<lpage>1236</lpage>.<pub-id pub-id-type="pmid">31410448</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="mco2454-cit-0071">
<string-name>
<surname>Yang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>MQ</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracorporeal cardiac shock wave&#x02010;induced exosome derived from endothelial colony&#x02010;forming cells carrying miR&#x02010;140&#x02010;3p alleviate cardiomyocyte hypoxia/reoxygenation injury via the PTEN/PI3K/AKT pathway</article-title>. <source>Front Cell Dev Biol</source>. <year>2022</year>;<volume>9</volume>:<elocation-id>779936</elocation-id>.<pub-id pub-id-type="pmid">35083214</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="mco2454-cit-0072">
<string-name>
<surname>Simoes</surname>
<given-names>FC</given-names>
</string-name>, <string-name>
<surname>Riley</surname>
<given-names>PR</given-names>
</string-name>. <article-title>The ontogeny, activation and function of the epicardium during heart development and regeneration</article-title>. <source>Development</source>. <year>2018</year>;<volume>145</volume>(<issue>7</issue>):<elocation-id>dev155994</elocation-id>.<pub-id pub-id-type="pmid">29592950</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="mco2454-cit-0073">
<string-name>
<surname>Del Campo</surname>
<given-names>CV</given-names>
</string-name>, <string-name>
<surname>Liaw</surname>
<given-names>NY</given-names>
</string-name>, <string-name>
<surname>Gunadasa&#x02010;Rohling</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Regenerative potential of epicardium&#x02010;derived extracellular vesicles mediated by conserved miRNA transfer</article-title>. <source>Cardiovasc Res</source>. <year>2022</year>;<volume>118</volume>(<issue>2</issue>):<fpage>597</fpage>&#x02010;<lpage>611</lpage>.<pub-id pub-id-type="pmid">33599250</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="mco2454-cit-0074">
<string-name>
<surname>Yuan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>. <article-title>Mechanism of miR&#x02010;378a&#x02010;3p enriched in M2 macrophage&#x02010;derived extracellular vesicles in cardiomyocyte pyroptosis after MI</article-title>. <source>Hypertens Res</source>. <year>2022</year>;<volume>45</volume>(<issue>4</issue>):<fpage>650</fpage>&#x02010;<lpage>664</lpage>.<pub-id pub-id-type="pmid">35082376</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="mco2454-cit-0075">
<string-name>
<surname>Dai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>M2 macrophage&#x02010;derived exosomes carry microRNA&#x02010;148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF&#x02010;kappaB/NLRP3 inflammasome signaling pathway</article-title>. <source>J Mol Cell Cardiol</source>. <year>2020</year>;<volume>142</volume>:<fpage>65</fpage>&#x02010;<lpage>79</lpage>.<pub-id pub-id-type="pmid">32087217</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="mco2454-cit-0076">
<string-name>
<surname>Long</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>M2 macrophage&#x02010;derived exosomes carry miR&#x02010;1271&#x02010;5p to alleviate cardiac injury in acute myocardial infarction through down&#x02010;regulating SOX6</article-title>. <source>Mol Immunol</source>. <year>2021</year>;<volume>136</volume>:<fpage>26</fpage>&#x02010;<lpage>35</lpage>.<pub-id pub-id-type="pmid">34058620</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="mco2454-cit-0077">
<string-name>
<surname>Zhai</surname>
<given-names>TY</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes released from CaSR&#x02010;stimulated PMNs reduce ischaemia/reperfusion injury</article-title>. <source>Oxid Med Cell Longev</source>. <year>2021</year>;<volume>2021</volume>:<elocation-id>3010548</elocation-id>.<pub-id pub-id-type="pmid">33505580</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="mco2454-cit-0078">
<string-name>
<surname>Luo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>microRNA&#x02010;423&#x02010;3p exosomes derived from cardiac fibroblasts mediates the cardioprotective effects of ischaemic post&#x02010;conditioning</article-title>. <source>Cardiovasc Res</source>. <year>2019</year>;<volume>115</volume>(<issue>7</issue>):<fpage>1189</fpage>&#x02010;<lpage>1204</lpage>.<pub-id pub-id-type="pmid">30202848</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="mco2454-cit-0079">
<string-name>
<surname>Hao</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>ZR</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>YY</given-names>
</string-name>, et&#x000a0;al. <article-title>Overexpression of GATA4 enhances the antiapoptotic effect of exosomes secreted from cardiac colony&#x02010;forming unit fibroblasts via miRNA221&#x02010;mediated targeting of the PTEN/PI3K/AKT signaling pathway</article-title>. <source>Stem Cell Res Ther</source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<fpage>251</fpage>.<pub-id pub-id-type="pmid">32586406</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="mco2454-cit-0080">
<string-name>
<surname>Bergmann</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Bhardwaj</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Bernard</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Evidence for cardiomyocyte renewal in humans</article-title>. <source>Science</source>. <year>2009</year>;<volume>324</volume>(<issue>5923</issue>):<fpage>98</fpage>&#x02010;<lpage>102</lpage>.<pub-id pub-id-type="pmid">19342590</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="mco2454-cit-0081">
<string-name>
<surname>Salybekov</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Kawaguchi</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Masuda</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Vorateera</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Okada</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Asahara</surname>
<given-names>T</given-names>
</string-name>. <article-title>Regeneration&#x02010;associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti&#x02010;inflammation, and cardiomyogenesis</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>11</issue>):<elocation-id>e0203244</elocation-id>.<pub-id pub-id-type="pmid">30485279</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="mco2454-cit-0082">
<string-name>
<surname>Salybekov</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Salybekova</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sheng</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles derived from regeneration associated cells preserve heart function after ischemia&#x02010;induced injury</article-title>. <source>Front Cardiovasc Med</source>. <year>2021</year>;<volume>8</volume>:<elocation-id>754254</elocation-id>.<pub-id pub-id-type="pmid">34746267</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="mco2454-cit-0083">
<string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Cardiac progenitor&#x02010;derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2013</year>;<volume>431</volume>(<issue>3</issue>):<fpage>566</fpage>&#x02010;<lpage>571</lpage>.<pub-id pub-id-type="pmid">23318173</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="mco2454-cit-0084">
<string-name>
<surname>Barile</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lionetti</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Cervio</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction</article-title>. <source>Cardiovasc Res</source>. <year>2014</year>;<volume>103</volume>(<issue>4</issue>):<fpage>530</fpage>&#x02010;<lpage>541</lpage>.<pub-id pub-id-type="pmid">25016614</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="mco2454-cit-0085">
<string-name>
<surname>Xiao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>XH</given-names>
</string-name>, et&#x000a0;al. <article-title>Cardiac progenitor cell&#x02010;derived exosomes prevent cardiomyocytes apoptosis through exosomal miR&#x02010;21 by targeting PDCD4</article-title>. <source>Cell Death Dis</source>. <year>2016</year>;<volume>7</volume>:<elocation-id>e2277</elocation-id>.<pub-id pub-id-type="pmid">27336721</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="mco2454-cit-0086">
<string-name>
<surname>Ciullo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Biemmi</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Milano</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomal expression of CXCR4 targets cardioprotective vesicles to myocardial infarction and improves outcome after systemic administration</article-title>. <source>Int J Mol Sci</source>. <year>2019</year>;<volume>20</volume>(<issue>3</issue>):<fpage>468</fpage>.<pub-id pub-id-type="pmid">30678240</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="mco2454-cit-0087">
<string-name>
<surname>Afzal</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Samanta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shah</surname>
<given-names>ZI</given-names>
</string-name>, et&#x000a0;al. <article-title>Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials</article-title>. <source>Circ Res</source>. <year>2015</year>;<volume>117</volume>(<issue>6</issue>):<fpage>558</fpage>&#x02010;<lpage>575</lpage>.<pub-id pub-id-type="pmid">26160853</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="mco2454-cit-0088">
<string-name>
<surname>Basso</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Corrado</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Marcus</surname>
<given-names>FI</given-names>
</string-name>, <string-name>
<surname>Nava</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Thiene</surname>
<given-names>G</given-names>
</string-name>. <article-title>Arrhythmogenic right ventricular cardiomyopathy</article-title>. <source>Lancet</source>. <year>2009</year>;<volume>373</volume>(<issue>9671</issue>):<fpage>1289</fpage>&#x02010;<lpage>1300</lpage>.<pub-id pub-id-type="pmid">19362677</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="mco2454-cit-0089">
<string-name>
<surname>Lin</surname>
<given-names>YN</given-names>
</string-name>, <string-name>
<surname>Mesquita</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sanchez</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles from immortalized cardiosphere&#x02010;derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein&#x02010;2 mutant mice</article-title>. <source>Eur Heart J</source>. <year>2021</year>;<volume>42</volume>(<issue>35</issue>):<fpage>3558</fpage>&#x02010;<lpage>3571</lpage>.<pub-id pub-id-type="pmid">34345905</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="mco2454-cit-0090">
<string-name>
<surname>Gallet</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dawkins</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Valle</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes secreted by cardiosphere&#x02010;derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction</article-title>. <source>Eur Heart J</source>. <year>2017</year>;<volume>38</volume>(<issue>3</issue>):<fpage>201</fpage>&#x02010;<lpage>211</lpage>.<pub-id pub-id-type="pmid">28158410</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="mco2454-cit-0091">
<string-name>
<surname>Ciullo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Biodistribution of unmodified cardiosphere&#x02010;derived cell extracellular vesicles using single RNA tracing</article-title>. <source>J Extracell Vesicles</source>. <year>2022</year>;<volume>11</volume>(<issue>1</issue>):<elocation-id>e12178</elocation-id>.<pub-id pub-id-type="pmid">35005847</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="mco2454-cit-0092">
<string-name>
<surname>Walravens</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Smolgovsky</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Mechanistic and therapeutic distinctions between cardiosphere&#x02010;derived cell and mesenchymal stem cell extracellular vesicle non&#x02010;coding RNA</article-title>. <source>Sci Rep</source>. <year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>8666</fpage>.<pub-id pub-id-type="pmid">33883598</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="mco2454-cit-0093">
<string-name>
<surname>Tan</surname>
<given-names>SJO</given-names>
</string-name>, <string-name>
<surname>Floriano</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Nicastro</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Emanueli</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Catapano</surname>
<given-names>F</given-names>
</string-name>. <article-title>Novel applications of mesenchymal stem cell&#x02010;derived exosomes for myocardial infarction therapeutics</article-title>. <source>Biomolecules</source>. <year>2020</year>;<volume>10</volume>(<issue>5</issue>):<fpage>707</fpage>.<pub-id pub-id-type="pmid">32370160</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="mco2454-cit-0094">
<string-name>
<surname>Williams</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Hare</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease</article-title>. <source>Circ Res</source>. <year>2011</year>;<volume>109</volume>(<issue>8</issue>):<fpage>923</fpage>&#x02010;<lpage>940</lpage>.<pub-id pub-id-type="pmid">21960725</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="mco2454-cit-0095">
<string-name>
<surname>Zhao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Mesenchymal stromal cell&#x02010;derived exosomes attenuate myocardial ischaemia&#x02013;reperfusion injury through miR&#x02010;182&#x02010;regulated macrophage polarization</article-title>. <source>Cardiovasc Res</source>. <year>2019</year>;<volume>115</volume>(<issue>7</issue>):<fpage>1205</fpage>&#x02010;<lpage>1216</lpage>.<pub-id pub-id-type="pmid">30753344</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="mco2454-cit-0096">
<string-name>
<surname>Yue</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Mesenchymal stem cell&#x02010;derived exosomal microRNA&#x02010;182&#x02010;5p alleviates myocardial ischemia/reperfusion injury by targeting GSDMD in mice</article-title>. <source>Cell Death Discov</source>. <year>2022</year>;<volume>8</volume>(<issue>1</issue>):<fpage>202</fpage>.<pub-id pub-id-type="pmid">35422485</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="mco2454-cit-0097">
<string-name>
<surname>Shen</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Mesenchymal stem cell&#x02010;derived exosomes regulate the polarization and inflammatory response of macrophages via miR&#x02010;21&#x02010;5p to promote repair after myocardial reperfusion injury</article-title>. <source>Ann Transl Med</source>. <year>2021</year>;<volume>9</volume>(<issue>16</issue>):<fpage>1323</fpage>.<pub-id pub-id-type="pmid">34532460</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="mco2454-cit-0098">
<string-name>
<surname>Liang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes of human umbilical cord MSCs protect against hypoxia/reoxygenation&#x02010;induced pyroptosis of cardiomyocytes via the miRNA&#x02010;100&#x02010;5p/FOXO3/NLRP3 pathway</article-title>. <source>Front Bioeng Biotechnol</source>. <year>2020</year>;<volume>8</volume>:<elocation-id>615850</elocation-id>.<pub-id pub-id-type="pmid">33520966</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="mco2454-cit-0099">
<string-name>
<surname>Patil</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Saheera</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dubey</surname>
<given-names>PK</given-names>
</string-name>, et&#x000a0;al. <article-title>Novel mechanisms of exosome&#x02010;mediated phagocytosis of dead cells in injured heart</article-title>. <source>Circ Res</source>. <year>2021</year>;<volume>129</volume>(<issue>11</issue>):<fpage>1006</fpage>&#x02010;<lpage>1020</lpage>.<pub-id pub-id-type="pmid">34623174</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="mco2454-cit-0100">
<string-name>
<surname>Wang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>DZ</given-names>
</string-name>, et&#x000a0;al. <article-title>Mesenchymal stem cells&#x02010;derived extracellular vesicles, via miR&#x02010;210, improve infarcted cardiac function by promotion of angiogenesis</article-title>. <source>Biochem Biophys Acta Mol Basis Dis</source>. <year>2017</year>;<volume>1863</volume>(<issue>8</issue>):<fpage>2085</fpage>&#x02010;<lpage>2092</lpage>.</mixed-citation></ref><ref id="mco2454-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="mco2454-cit-0101">
<string-name>
<surname>Guo</surname>
<given-names>ZY</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>CL</given-names>
</string-name>. <article-title>Transfer of microRNA&#x02010;221 from mesenchymal stem cell&#x02010;derived extracellular vesicles inhibits atherosclerotic plaque formation</article-title>. <source>Transl Res</source>. <year>2020</year>;<volume>226</volume>:<fpage>83</fpage>&#x02010;<lpage>95</lpage>.<pub-id pub-id-type="pmid">32659442</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="mco2454-cit-0102">
<string-name>
<surname>Yu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>H</given-names>
</string-name>. <article-title>Mesenchymal stem cell&#x02010;originated exosomal Lnc A2M&#x02010;AS1 alleviates hypoxia/reperfusion&#x02010;induced apoptosis and oxidative stress in cardiomyocytes</article-title>. <source>Cardiovasc Drugs Ther</source>. <year>2022</year>;<volume>37</volume>(<issue>5</issue>):<fpage>891</fpage>&#x02010;<lpage>904</lpage>.<pub-id pub-id-type="pmid">35543792</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="mco2454-cit-0103">
<string-name>
<surname>Sun</surname>
<given-names>XH</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hui</surname>
<given-names>J</given-names>
</string-name>. <article-title>Exosomes of bone&#x02010;marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR&#x02010;486&#x02010;5p targeting the PTEN/PI3K/AKT signaling pathway</article-title>. <source>Thromb Res</source>. <year>2019</year>;<volume>177</volume>:<fpage>23</fpage>&#x02010;<lpage>32</lpage>.<pub-id pub-id-type="pmid">30844685</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="mco2454-cit-0104">
<string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mao</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>IFN&#x02010;gamma enhances the efficacy of mesenchymal stromal cell&#x02010;derived exosomes via miR&#x02010;21 in myocardial infarction rats</article-title>. <source>Stem Cell Res Ther</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>333</fpage>.<pub-id pub-id-type="pmid">35870960</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="mco2454-cit-0105">
<string-name>
<surname>Li</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>LncRNA HCP5 in hBMSC&#x02010;derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR&#x02010;497 to activate IGF1/PI3K/AKT pathway</article-title>. <source>Int J Cardiol</source>. <year>2021</year>;<volume>342</volume>:<fpage>72</fpage>&#x02010;<lpage>81</lpage>.<pub-id pub-id-type="pmid">34311013</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="mco2454-cit-0106">
<string-name>
<surname>Cuervo</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Autophagy: many paths to the same end</article-title>. <source>Mol Cell Biochem</source>. <year>2004</year>;<volume>263</volume>(<issue>1</issue>):<fpage>55</fpage>&#x02010;<lpage>72</lpage>.</mixed-citation></ref><ref id="mco2454-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="mco2454-cit-0107">
<string-name>
<surname>Xiao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR&#x02010;125b</article-title>. <source>Circ Res</source>. <year>2018</year>;<volume>123</volume>(<issue>5</issue>):<fpage>564</fpage>&#x02010;<lpage>578</lpage>.<pub-id pub-id-type="pmid">29921652</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="mco2454-cit-0108">
<string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ruan</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>C</given-names>
</string-name>. <article-title>Mesenchymal stem cell&#x02010;derived exosomal miR&#x02010;143&#x02010;3p suppresses myocardial ischemia&#x02013;reperfusion injury by regulating autophagy</article-title>. <source>Life Sci</source>. <year>2021</year>;<volume>280</volume>:<elocation-id>119742</elocation-id>.<pub-id pub-id-type="pmid">34166712</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="mco2454-cit-0109">
<string-name>
<surname>Mao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles from anoxia preconditioned mesenchymal stem cells alleviate myocardial ischemia/reperfusion injury</article-title>. <source>Aging</source>. <year>2021</year>;<volume>13</volume>(<issue>4</issue>):<fpage>6156</fpage>&#x02010;<lpage>6170</lpage>.<pub-id pub-id-type="pmid">33578393</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="mco2454-cit-0110">
<string-name>
<surname>Mao</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>DJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles from hypoxia&#x02010;preconditioned mesenchymal stem cells alleviates myocardial injury by targeting thioredoxin&#x02010;interacting protein&#x02010;mediated hypoxia&#x02010;inducible factor&#x02010;1alpha pathway</article-title>. <source>World J Stem Cells</source>. <year>2022</year>;<volume>14</volume>(<issue>2</issue>):<fpage>183</fpage>&#x02010;<lpage>199</lpage>.<pub-id pub-id-type="pmid">35432732</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="mco2454-cit-0111">
<string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomal microRNA&#x02010;98&#x02010;5p from hypoxic bone marrow mesenchymal stem cells inhibits myocardial ischemia&#x02013;reperfusion injury by reducing TLR4 and activating the PI3K/Akt signaling pathway</article-title>. <source>Int Immunopharmacol</source>. <year>2021</year>;<volume>101(pt B)</volume>:<elocation-id>107592</elocation-id>.<pub-id pub-id-type="pmid">34715573</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="mco2454-cit-0112">
<string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>PC</given-names>
</string-name>, et&#x000a0;al. <article-title>Long noncoding RNA UCA1 from hypoxia&#x02010;conditioned hMSC&#x02010;derived exosomes: a novel molecular target for cardioprotection through miR&#x02010;873&#x02010;5p/XIAP axis</article-title>. <source>Cell Death Dis</source>. <year>2020</year>;<volume>11</volume>(<issue>8</issue>):<fpage>696</fpage>.<pub-id pub-id-type="pmid">32826854</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="mco2454-cit-0113">
<string-name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sadoshima</surname>
<given-names>J</given-names>
</string-name>. <article-title>Mechanisms of physiological and pathological cardiac hypertrophy</article-title>. <source>Nat Rev Cardiol</source>. <year>2018</year>;<volume>15</volume>(<issue>7</issue>):<fpage>387</fpage>&#x02010;<lpage>407</lpage>.<pub-id pub-id-type="pmid">29674714</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="mco2454-cit-0114">
<string-name>
<surname>Lu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles DJ&#x02010;1 derived from hypoxia&#x02010;conditioned hMSCs alleviate cardiac hypertrophy by suppressing mitochondria dysfunction and preventing ATRAP degradation</article-title>. <source>Pharmacol Res</source>. <year>2023</year>;<volume>187</volume>:<elocation-id>106607</elocation-id>.<pub-id pub-id-type="pmid">36509316</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="mco2454-cit-0115">
<string-name>
<surname>Cui</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>. <article-title>Exosomes from adipose&#x02010;derived mesenchymal stem cells protect the myocardium against ischemia/reperfusion injury through Wnt/beta&#x02010;catenin signaling pathway</article-title>. <source>J Cardiovasc Pharmacol</source>. <year>2017</year>;<volume>70</volume>(<issue>4</issue>):<fpage>225</fpage>&#x02010;<lpage>231</lpage>.<pub-id pub-id-type="pmid">28582278</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="mco2454-cit-0116">
<string-name>
<surname>Lai</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>YC</given-names>
</string-name>, et&#x000a0;al. <article-title>MicroRNA&#x02010;221/222 mediates ADSC&#x02010;exosome&#x02010;induced cardioprotection against ischemia/reperfusion by targeting PUMA and ETS&#x02010;1</article-title>. <source>Front Cell Dev Biol</source>. <year>2020</year>;<volume>8</volume>:<elocation-id>569150</elocation-id>.<pub-id pub-id-type="pmid">33344446</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="mco2454-cit-0117">
<string-name>
<surname>Liu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>YD</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>YG</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>. <article-title>Exosomes from adipose&#x02010;derived mesenchymal stem cells prevent cardiomyocyte apoptosis induced by oxidative stress</article-title>. <source>Cell Death Discov</source>. <year>2019</year>;<volume>5</volume>:<fpage>79</fpage>.<pub-id pub-id-type="pmid">30911413</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="mco2454-cit-0118">
<string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes derived from human umbilical cord mesenchymal stem cells relieve acute myocardial ischemic injury</article-title>. <source>Stem Cells Int</source>. <year>2015</year>;<volume>2015</volume>:<elocation-id>761643</elocation-id>.<pub-id pub-id-type="pmid">26106430</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="mco2454-cit-0119">
<string-name>
<surname>Song</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Human umbilical cord blood&#x02010;derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice</article-title>. <source>Cell Biol Toxicol</source>. <year>2021</year>;<volume>37</volume>(<issue>1</issue>):<fpage>51</fpage>&#x02010;<lpage>64</lpage>.<pub-id pub-id-type="pmid">32535745</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="mco2454-cit-0120">
<string-name>
<surname>Sagar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>PP</given-names>
</string-name>. <article-title>Myocarditis</article-title>. <source>Lancet</source>. <year>2012</year>;<volume>379</volume>(<issue>9817</issue>):<fpage>738</fpage>&#x02010;<lpage>747</lpage>.<pub-id pub-id-type="pmid">22185868</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="mco2454-cit-0121">
<string-name>
<surname>Gu</surname>
<given-names>XH</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>KX</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes derived from umbilical cord mesenchymal stem cells alleviate viral myocarditis through activating AMPK/mTOR&#x02010;mediated autophagy flux pathway</article-title>. <source>J Cell Mol Med</source>. <year>2020</year>;<volume>24</volume>(<issue>13</issue>):<fpage>7515</fpage>&#x02010;<lpage>7530</lpage>.<pub-id pub-id-type="pmid">32424968</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="mco2454-cit-0122">
<string-name>
<surname>Diao</surname>
<given-names>LW</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>QH</given-names>
</string-name>. <article-title>Transfer of lncRNA UCA1 by hUCMSCs&#x02010;derived exosomes protects against hypoxia/reoxygenation injury through impairing miR&#x02010;143&#x02010;targeted degradation of Bcl&#x02010;2</article-title>. <source>Aging</source>. <year>2021</year>;<volume>13</volume>(<issue>4</issue>):<fpage>5967</fpage>&#x02010;<lpage>5985</lpage>.<pub-id pub-id-type="pmid">33591946</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="mco2454-cit-0123">
<string-name>
<surname>Wang</surname>
<given-names>XL</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes derived from human umbilical cord mesenchymal stem cells improve myocardial repair via upregulation of Smad7</article-title>. <source>Int J Mol Med</source>. <year>2018</year>;<volume>41</volume>(<issue>5</issue>):<fpage>3063</fpage>&#x02010;<lpage>3072</lpage>.<pub-id pub-id-type="pmid">29484378</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="mco2454-cit-0124">
<string-name>
<surname>Huang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>You</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Human umbilical cord mesenchymal stem cells&#x02010;derived exosomes transfers microRNA&#x02010;19a to protect cardiomyocytes from acute myocardial infarction by targeting SOX6</article-title>. <source>Cell Cycle</source>. <year>2020</year>;<volume>19</volume>(<issue>3</issue>):<fpage>339</fpage>&#x02010;<lpage>353</lpage>.<pub-id pub-id-type="pmid">31924121</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="mco2454-cit-0125">
<string-name>
<surname>Takov</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Johnston</surname>
<given-names>HE</given-names>
</string-name>, et&#x000a0;al. <article-title>Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential</article-title>. <source>Basic Res Cardiol</source>. <year>2020</year>;<volume>115</volume>(<issue>3</issue>):<fpage>26</fpage>.<pub-id pub-id-type="pmid">32146560</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="mco2454-cit-0126">
<string-name>
<surname>Wang</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>LN</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>HM</given-names>
</string-name>. <article-title>Distinct patterns of histone modifications at cardiac&#x02010;specific gene promoters between cardiac stem cells and mesenchymal stem cells</article-title>. <source>Am J Physiol&#x02010;Cell Ph</source>. <year>2013</year>;<volume>304</volume>(<issue>11</issue>):<fpage>C1080</fpage>&#x02010;<lpage>C1090</lpage>.</mixed-citation></ref><ref id="mco2454-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="mco2454-cit-0127">
<string-name>
<surname>Xuan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ashraf</surname>
<given-names>M</given-names>
</string-name>. <article-title>Extracellular vesicles from notch activated cardiac mesenchymal stem cells promote myocyte proliferation and neovasculogenesis</article-title>. <source>Front Cell Dev Biol</source>. <year>2020</year>;<volume>8</volume>:<fpage>11</fpage>.<pub-id pub-id-type="pmid">32154243</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="mco2454-cit-0128">
<string-name>
<surname>Li</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Cardiac repair in a mouse model of acute myocardial infarction with trophoblast stem cells</article-title>. <source>Sci Rep</source>. <year>2017</year>;<volume>7</volume>:<elocation-id>44376</elocation-id>.<pub-id pub-id-type="pmid">28295048</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="mco2454-cit-0129">
<string-name>
<surname>Ni</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>LA</given-names>
</string-name>, et&#x000a0;al. <article-title>Human trophoblast&#x02010;derived exosomes attenuate doxorubicin&#x02010;induced cardiac injury by regulating miR&#x02010;200b and downstream Zeb1</article-title>. <source>J Nanobiotechnol</source>. <year>2020</year>;<volume>18</volume>(<issue>1</issue>):<fpage>171</fpage>.</mixed-citation></ref><ref id="mco2454-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="mco2454-cit-0130">
<string-name>
<surname>Katsur</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Vinokur</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Corteling</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yellon</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Davidson</surname>
<given-names>SM</given-names>
</string-name>. <article-title>Exosomes from neuronal stem cells may protect the heart from ischaemia/reperfusion injury via JAK1/2 and gp130</article-title>. <source>J Cell Mol Med</source>. <year>2021</year>;<volume>25</volume>(<issue>9</issue>):<fpage>4455</fpage>&#x02010;<lpage>4465</lpage>.<pub-id pub-id-type="pmid">33797200</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="mco2454-cit-0131">
<string-name>
<surname>Schena</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Murray</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Hildebrand</surname>
<given-names>AN</given-names>
</string-name>, et&#x000a0;al. <article-title>Cortical bone stem cell&#x02010;derived exosomes' therapeutic effect on myocardial ischemia&#x02013;reperfusion and cardiac remodeling</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2021</year>;<volume>321</volume>(<issue>6</issue>):<fpage>H1014</fpage>&#x02010;<lpage>H1029</lpage>.<pub-id pub-id-type="pmid">34623184</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="mco2454-cit-0132">
<string-name>
<surname>Mayhall</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Paffett&#x02010;Lugassy</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zon</surname>
<given-names>LI</given-names>
</string-name>. <article-title>The clinical potential of stem cells</article-title>. <source>Curr Opin Cell Biol</source>. <year>2004</year>;<volume>16</volume>(<issue>6</issue>):<fpage>713</fpage>&#x02010;<lpage>720</lpage>.<pub-id pub-id-type="pmid">15530786</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="mco2454-cit-0133">
<string-name>
<surname>Khan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nickoloff</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Abramova</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Embryonic stem cell&#x02010;derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction</article-title>. <source>Circ Res</source>. <year>2015</year>;<volume>117</volume>(<issue>1</issue>):<fpage>52</fpage>&#x02010;<lpage>64</lpage>.<pub-id pub-id-type="pmid">25904597</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="mco2454-cit-0134">
<string-name>
<surname>El Harane</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kervadec</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bellamy</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. <article-title>Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors</article-title>. <source>Eur Heart J</source>. <year>2018</year>;<volume>39</volume>(<issue>20</issue>):<fpage>1835</fpage>&#x02010;<lpage>1847</lpage>.<pub-id pub-id-type="pmid">29420830</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="mco2454-cit-0135">
<string-name>
<surname>Adamiak</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bobis&#x02010;Wozowicz</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Induced pluripotent stem cell (iPSC)&#x02010;derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs</article-title>. <source>Circ Res</source>. <year>2018</year>;<volume>122</volume>(<issue>2</issue>):<fpage>296</fpage>&#x02010;<lpage>309</lpage>.<pub-id pub-id-type="pmid">29118058</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="mco2454-cit-0136">
<string-name>
<surname>Han</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pei</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Highly efficient magnetic labelling allows MRI tracking of the homing of stem cell&#x02010;derived extracellular vesicles following systemic delivery</article-title>. <source>J Extracell Vesicles</source>. <year>2021</year>;<volume>10</volume>(<issue>3</issue>):<elocation-id>e12054</elocation-id>.<pub-id pub-id-type="pmid">33489014</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="mco2454-cit-0137">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium</article-title>. <source>Int J Cardiol</source>. <year>2015</year>;<volume>192</volume>:<fpage>61</fpage>&#x02010;<lpage>69</lpage>.<pub-id pub-id-type="pmid">26000464</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="mco2454-cit-0138">
<string-name>
<surname>Gao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes secreted by hiPSC&#x02010;derived cardiac cells improve recovery from myocardial infarction in swine</article-title>. <source>Sci Transl Med</source>. <year>2020</year>;<volume>12</volume>(<issue>561</issue>):<elocation-id>eaay1318</elocation-id>.<pub-id pub-id-type="pmid">32938792</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="mco2454-cit-0139">
<string-name>
<surname>Chong</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Don</surname>
<given-names>CW</given-names>
</string-name>, et&#x000a0;al. <article-title>Human embryonic&#x02010;stem&#x02010;cell&#x02010;derived cardiomyocytes regenerate non&#x02010;human primate hearts</article-title>. <source>Nature</source>. <year>2014</year>;<volume>510</volume>(<issue>7504</issue>):<fpage>273</fpage>&#x02010;<lpage>277</lpage>.<pub-id pub-id-type="pmid">24776797</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="mco2454-cit-0140">
<string-name>
<surname>Jung</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Ikeda</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tada</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>miR&#x02010;106a&#x02010;363 cluster in extracellular vesicles promotes endogenous myocardial repair via Notch3 pathway in ischemic heart injury</article-title>. <source>Basic Res Cardiol</source>. <year>2021</year>;<volume>116</volume>(<issue>1</issue>):<fpage>19</fpage>.<pub-id pub-id-type="pmid">33742276</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="mco2454-cit-0141">
<string-name>
<surname>Ikeda</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Santoso</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Tada</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Mitochondria&#x02010;rich extracellular vesicles from autologous stem cell&#x02010;derived cardiomyocytes restore energetics of ischemic myocardium</article-title>. <source>J Am Coll Cardiol</source>. <year>2021</year>;<volume>77</volume>(<issue>8</issue>):<fpage>1073</fpage>&#x02010;<lpage>1088</lpage>.<pub-id pub-id-type="pmid">33632482</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="mco2454-cit-0142">
<string-name>
<surname>Wu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>WLW</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles from human embryonic stem cell&#x02010;derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis</article-title>. <source>Cell Death Dis</source>. <year>2020</year>;<volume>11</volume>(<issue>5</issue>):<fpage>354</fpage>.<pub-id pub-id-type="pmid">32393784</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="mco2454-cit-0143">
<string-name>
<surname>Mattapally</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Fast</surname>
<given-names>VG</given-names>
</string-name>, et&#x000a0;al. <article-title>Spheroids of cardiomyocytes derived from human&#x02010;induced pluripotent stem cells improve recovery from myocardial injury in mice</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2018</year>;<volume>315</volume>(<issue>2</issue>):<fpage>H327</fpage>&#x02010;<lpage>H339</lpage>.<pub-id pub-id-type="pmid">29631371</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="mco2454-cit-0144">
<string-name>
<surname>D'Ascenzo</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Femmino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ravera</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles from patients with acute coronary syndrome impact on ischemia&#x02013;reperfusion injury</article-title>. <source>Pharmacol Res</source>. <year>2021</year>;<volume>170</volume>:<elocation-id>105715</elocation-id>.<pub-id pub-id-type="pmid">34111564</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="mco2454-cit-0145">
<string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>. <article-title>Ischaemic preconditioning&#x02010;induced serum exosomes protect against myocardial ischaemia/reperfusion injury in rats by activating the PI3K/AKT signalling pathway</article-title>. <source>Cell Biochem Funct</source>. <year>2021</year>;<volume>39</volume>(<issue>2</issue>):<fpage>287</fpage>&#x02010;<lpage>295</lpage>.<pub-id pub-id-type="pmid">32767595</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="mco2454-cit-0146">
<string-name>
<surname>Jiang</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Qiu</surname>
<given-names>LW</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>YF</given-names>
</string-name>, <string-name>
<surname>Zuo</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>XF</given-names>
</string-name>. <article-title>The potential role of circulating exosomes in protecting myocardial injury in acute myocardial infarction via regulating miR&#x02010;190a&#x02010;3p/CXCR4/CXCL12 pathway</article-title>. <source>J Bioenerg Biomembr</source>. <year>2022</year>;<volume>54</volume>(<issue>4</issue>):<fpage>175</fpage>&#x02010;<lpage>189</lpage>.<pub-id pub-id-type="pmid">35867293</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="mco2454-cit-0147">
<string-name>
<surname>Hosen</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>YY</given-names>
</string-name>, et&#x000a0;al. <article-title>CAD increases the long noncoding RNA PUNISHER in small extracellular vesicles and regulates endothelial cell function via vesicular shuttling</article-title>. <source>Mol Ther&#x02010;Nucl Acids</source>. <year>2021</year>;<volume>25</volume>:<fpage>388</fpage>&#x02010;<lpage>405</lpage>.</mixed-citation></ref><ref id="mco2454-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="mco2454-cit-0148">
<string-name>
<surname>Vicencio</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Yellon</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Sivaraman</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. <article-title>Plasma exosomes protect the myocardium from ischemia&#x02013;reperfusion injury</article-title>. <source>J Am Coll Cardiol</source>. <year>2015</year>;<volume>65</volume>(<issue>15</issue>):<fpage>1525</fpage>&#x02010;<lpage>1536</lpage>.<pub-id pub-id-type="pmid">25881934</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="mco2454-cit-0149">
<string-name>
<surname>Luo</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Plasma exosomes generated by ischaemic preconditioning are cardioprotective in a rat heart failure model</article-title>. <source>Br J Anaesth</source>. <year>2023</year>;<volume>130</volume>(<issue>1</issue>):<fpage>29</fpage>&#x02010;<lpage>38</lpage>.<pub-id pub-id-type="pmid">36347723</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="mco2454-cit-0150">
<string-name>
<surname>Yu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Plasma&#x02010;derived extracellular vesicles transfer microRNA&#x02010;130a&#x02010;3p to alleviate myocardial ischemia/reperfusion injury by targeting ATG16L1</article-title>. <source>Cell Tissue Res</source>. <year>2022</year>;<volume>389</volume>(<issue>1</issue>):<fpage>99</fpage>&#x02010;<lpage>114</lpage>.<pub-id pub-id-type="pmid">35503135</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="mco2454-cit-0151">
<string-name>
<surname>Lin</surname>
<given-names>BY</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>CH</given-names>
</string-name>, et&#x000a0;al. <article-title>Loss of exosomal LncRNA HCG15 prevents acute myocardial ischemic injury through the NF&#x02010;kappa B/p65 and p38 pathways</article-title>. <source>Cell Death Dis</source>. <year>2021</year>;<volume>12</volume>(<issue>11</issue>):<fpage>1007</fpage>.<pub-id pub-id-type="pmid">34707098</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="mco2454-cit-0152">
<string-name>
<surname>Liu</surname>
<given-names>ZY</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>DD</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>FC</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomal miR&#x02010;17&#x02010;3p Alleviates Programmed Necrosis in Cardiac Ischemia/Reperfusion Injury by Regulating TIMP3 Expression</article-title>. <source>Oxid Med Cell Long</source>. <year>2022</year>;<volume>2022</volume>:<elocation-id>2785113</elocation-id>.</mixed-citation></ref><ref id="mco2454-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="mco2454-cit-0153">
<string-name>
<surname>Giricz</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Varga</surname>
<given-names>ZV</given-names>
</string-name>, <string-name>
<surname>Baranyai</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles</article-title>. <source>J Mol Cell Cardiol</source>. <year>2014</year>;<volume>68</volume>:<fpage>75</fpage>&#x02010;<lpage>78</lpage>.<pub-id pub-id-type="pmid">24440457</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="mco2454-cit-0154">
<string-name>
<surname>Lassen</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Just</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hjortbak</surname>
<given-names>MV</given-names>
</string-name>, et&#x000a0;al. <article-title>Cardioprotection by remote ischemic conditioning is transferable by plasma and mediated by extracellular vesicles</article-title>. <source>Basic Res Cardiol</source>. <year>2021</year>;<volume>116</volume>(<issue>1</issue>):<fpage>16</fpage>.<pub-id pub-id-type="pmid">33689033</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="mco2454-cit-0155">
<string-name>
<surname>Minghua</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhijian</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Chahua</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Plasma exosomes induced by remote ischaemic preconditioning attenuate myocardial ischaemia/reperfusion injury by transferring miR&#x02010;24</article-title>. <source>Cell Death Dis</source>. <year>2018</year>;<volume>9</volume>(<issue>3</issue>):<fpage>320</fpage>.<pub-id pub-id-type="pmid">29476052</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="mco2454-cit-0156">
<string-name>
<surname>Li</surname>
<given-names>DN</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>SQ</given-names>
</string-name>. <article-title>Plasma exosomes at the late phase of remote ischemic pre&#x02010;conditioning attenuate myocardial ischemia&#x02013;reperfusion injury through transferring miR&#x02010;126a&#x02010;3p</article-title>. <source>Front Cardiovasc Med</source>. <year>2021</year>;<volume>8</volume>:<elocation-id>736226</elocation-id>.<pub-id pub-id-type="pmid">34917657</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="mco2454-cit-0157">
<string-name>
<surname>Wang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Dysregulation of miR&#x02010;342&#x02010;3p in plasma exosomes derived from convalescent AMI patients and its consequences on cardiac repair</article-title>. <source>Biomed Pharmacother</source>. <year>2021</year>;<volume>142</volume>:<elocation-id>112056</elocation-id>.<pub-id pub-id-type="pmid">34435593</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0158"><label>158</label><mixed-citation publication-type="journal" id="mco2454-cit-0158">
<string-name>
<surname>Pecan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hambalko</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ha</surname>
<given-names>VT</given-names>
</string-name>, et&#x000a0;al. <article-title>Calcium ionophore&#x02010;induced extracellular vesicles mediate cytoprotection against simulated ischemia/reperfusion injury in cardiomyocyte&#x02010;derived cell lines by inducing heme oxygenase 1</article-title>. <source>Int J Mol Sci</source>. <year>2020</year>;<volume>21</volume>(<issue>20</issue>):<fpage>7687</fpage>.<pub-id pub-id-type="pmid">33081396</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="mco2454-cit-0159">
<string-name>
<surname>Crewe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Funcke</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicle&#x02010;based interorgan transport of mitochondria from energetically stressed adipocytes</article-title>. <source>Cell Metab</source>. <year>2021</year>;<volume>33</volume>(<issue>9</issue>):<fpage>1853</fpage>&#x02010;<lpage>1868</lpage>.e11.<pub-id pub-id-type="pmid">34418352</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="mco2454-cit-0160">
<string-name>
<surname>van Niel</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>D'Angelo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Raposo</surname>
<given-names>G</given-names>
</string-name>. <article-title>Shedding light on the cell biology of extracellular vesicles</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2018</year>;<volume>19</volume>(<issue>4</issue>):<fpage>213</fpage>&#x02010;<lpage>228</lpage>.<pub-id pub-id-type="pmid">29339798</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="mco2454-cit-0161">
<string-name>
<surname>Wei</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Qiao</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>miRNA&#x02010;181a over&#x02010;expression in mesenchymal stem cell&#x02010;derived exosomes influenced inflammatory response after myocardial ischemia&#x02013;reperfusion injury</article-title>. <source>Life Sci</source>. <year>2019</year>;<volume>232</volume>:<elocation-id>116632</elocation-id>.<pub-id pub-id-type="pmid">31278944</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="mco2454-cit-0162">
<string-name>
<surname>Wang</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Deci</surname>
<given-names>MB</given-names>
</string-name>, et&#x000a0;al. <article-title>MiR&#x02010;101a loaded extracellular nanovesicles as bioactive carriers for cardiac repair</article-title>. <source>Nanomed&#x02010;Nanotechnol</source>. <year>2020</year>;<volume>27</volume>:<elocation-id>102201</elocation-id>.</mixed-citation></ref><ref id="mco2454-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="mco2454-cit-0163">
<string-name>
<surname>Zhu</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>QJ</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes derived from mir&#x02010;214&#x02010;3p overexpressing mesenchymal stem cells promote myocardial repair</article-title>. <source>Biomater Res</source>. <year>2023</year>;<volume>27</volume>(<issue>1</issue>):<fpage>77</fpage>.<pub-id pub-id-type="pmid">37563655</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="mco2454-cit-0164">
<string-name>
<surname>Wei</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment</article-title>. <source>Biomaterials</source>. <year>2021</year>;<volume>275</volume>:<elocation-id>121000</elocation-id>.<pub-id pub-id-type="pmid">34218049</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="mco2454-cit-0165">
<string-name>
<surname>Liu</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>SQ</given-names>
</string-name>, et&#x000a0;al. <article-title>miR&#x02010;93&#x02010;5p&#x02010;containing exosomes treatment attenuates acute myocardial infarction&#x02010;induced myocardial damage</article-title>. <source>Mol Ther&#x02010;Nucl Acids</source>. <year>2018</year>;<volume>11</volume>:<fpage>103</fpage>&#x02010;<lpage>115</lpage>.</mixed-citation></ref><ref id="mco2454-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="mco2454-cit-0166">
<string-name>
<surname>Ni</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>YW</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Exosomes derived from TIMP2&#x02010;modified human umbilical cord mesenchymal stem cells enhance the repair effect in rat model with myocardial infarction possibly by the Akt/Sfrp2 pathway</article-title>. <source>Oxid Med Cell Longev</source>. <year>2019</year>;<volume>2019</volume>:<elocation-id>1958941</elocation-id>.<pub-id pub-id-type="pmid">31182988</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="mco2454-cit-0167">
<string-name>
<surname>Zhang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Q</given-names>
</string-name>. <article-title>Exosomal miR&#x02010;27b&#x02010;3p derived from hypoxic cardiac microvascular endothelial cells alleviates rat myocardial ischemia/reperfusion injury through inhibiting oxidative stress&#x02010;induced pyroptosis via Foxo1/GSDMD signaling</article-title>. <source>Oxid Med Cell Longev</source>. <year>2022</year>;<volume>2022</volume>:<elocation-id>8215842</elocation-id>.<pub-id pub-id-type="pmid">35847592</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="mco2454-cit-0168">
<string-name>
<surname>Liu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>Cardiac fibroblasts secrete exosome microRNA to suppress cardiomyocyte pyroptosis in myocardial ischemia/reperfusion injury</article-title>. <source>Mol Cell Biochem</source>. <year>2022</year>;<volume>477</volume>(<issue>4</issue>):<fpage>1249</fpage>&#x02010;<lpage>1260</lpage>.<pub-id pub-id-type="pmid">35119583</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="mco2454-cit-0169">
<string-name>
<surname>Kwon</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Schumacher</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>Characterization of betaARKct engineered cellular extracellular vesicles and model specific cardioprotection</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2021</year>;<volume>320</volume>(<issue>4</issue>):<fpage>H1276</fpage>&#x02010;<lpage>H1289</lpage>.<pub-id pub-id-type="pmid">33513081</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="mco2454-cit-0170">
<string-name>
<surname>Song</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>JX</given-names>
</string-name>, et&#x000a0;al. <article-title>Localized injection of miRNA&#x02010;21&#x02010;enriched extracellular vesicles effectively restores cardiac function after myocardial infarction</article-title>. <source>Theranostics</source>. <year>2019</year>;<volume>9</volume>(<issue>8</issue>):<fpage>2346</fpage>&#x02010;<lpage>2360</lpage>.<pub-id pub-id-type="pmid">31149048</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="mco2454-cit-0171">
<string-name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Tongxinluo&#x02010;pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR&#x02010;146a&#x02010;5p targeting IRAK1/NF&#x02010;kappaB p65 pathway</article-title>. <source>Stem Cell Res Ther</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>289</fpage>.<pub-id pub-id-type="pmid">35799283</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="mco2454-cit-0172">
<string-name>
<surname>Fu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosomes derived from MSC pre&#x02010;treated with oridonin alleviates myocardial IR injury by suppressing apoptosis via regulating autophagy activation</article-title>. <source>J Cell Mol Med</source>. <year>2021</year>;<volume>25</volume>(<issue>12</issue>):<fpage>5486</fpage>&#x02010;<lpage>5496</lpage>.<pub-id pub-id-type="pmid">33955654</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0173"><label>173</label><mixed-citation publication-type="journal" id="mco2454-cit-0173">
<string-name>
<surname>Deng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Irisin&#x02010;pretreated BMMSCs secrete exosomes to alleviate cardiomyocytes pyroptosis and oxidative stress to hypoxia/reoxygenation injury</article-title>. <source>Curr Stem Cell Res Ther</source>. <year>2022</year>;<volume>18</volume>(<issue>6</issue>):<fpage>843</fpage>&#x02010;<lpage>852</lpage>.</mixed-citation></ref><ref id="mco2454-bib-0174"><label>174</label><mixed-citation publication-type="journal" id="mco2454-cit-0174">
<string-name>
<surname>Ning</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>GH</given-names>
</string-name>, et&#x000a0;al. <article-title>Atorvastatin&#x02010;pretreated mesenchymal stem cell&#x02010;derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA&#x02010;139&#x02010;3p/Stat1 pathway</article-title>. <source>Bmc Med</source>. <year>2023</year>;<volume>21</volume>(<issue>1</issue>):<fpage>96</fpage>.<pub-id pub-id-type="pmid">36927608</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0175"><label>175</label><mixed-citation publication-type="journal" id="mco2454-cit-0175">
<string-name>
<surname>Huang</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells&#x02010;derived exosomes in acute myocardial infarction via up&#x02010;regulating long non&#x02010;coding RNA H19</article-title>. <source>Cardiovasc Res</source>. <year>2020</year>;<volume>116</volume>(<issue>2</issue>):<fpage>353</fpage>&#x02010;<lpage>367</lpage>.<pub-id pub-id-type="pmid">31119268</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0176"><label>176</label><mixed-citation publication-type="journal" id="mco2454-cit-0176">
<string-name>
<surname>Zheng</surname>
<given-names>HF</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>XT</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>Hemin enhances the cardioprotective effects of mesenchymal stem cell&#x02010;derived exosomes against infarction via amelioration of cardiomyocyte senescence</article-title>. <source>J Nanobiotechnol</source>. <year>2021</year>;<volume>19</volume>(<issue>1</issue>):<fpage>332</fpage>.</mixed-citation></ref><ref id="mco2454-bib-0177"><label>177</label><mixed-citation publication-type="journal" id="mco2454-cit-0177">
<string-name>
<surname>Zhang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>YA</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>ZY</given-names>
</string-name>, et&#x000a0;al. <article-title>Monocyte mimics improve mesenchymal stem cell&#x02010;derived extracellular vesicle homing in a mouse MI/RI model</article-title>. <source>Biomaterials</source>. <year>2020</year>;<volume>255</volume>:<elocation-id>120168</elocation-id>.<pub-id pub-id-type="pmid">32562944</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0178"><label>178</label><mixed-citation publication-type="journal" id="mco2454-cit-0178">
<string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeted immunomodulation therapy for cardiac repair by platelet membrane engineering extracellular vesicles via hitching peripheral monocytes</article-title>. <source>Biomaterials</source>. <year>2022</year>;<volume>284</volume>:<elocation-id>121529</elocation-id>.<pub-id pub-id-type="pmid">35447403</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0179"><label>179</label><mixed-citation publication-type="journal" id="mco2454-cit-0179">
<string-name>
<surname>Hu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury</article-title>. <source>Nano Today</source>. <year>2021</year>;<volume>39</volume>:<elocation-id>101210</elocation-id>.<pub-id pub-id-type="pmid">34306170</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0180"><label>180</label><mixed-citation publication-type="journal" id="mco2454-cit-0180">
<string-name>
<surname>Antes</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Middleton</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Luther</surname>
<given-names>KM</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display</article-title>. <source>J Nanobiotechnol</source>. <year>2018</year>;<volume>16</volume>:<fpage>61</fpage>.</mixed-citation></ref><ref id="mco2454-bib-0181"><label>181</label><mixed-citation publication-type="journal" id="mco2454-cit-0181">
<string-name>
<surname>Vandergriff</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide</article-title>. <source>Theranostics</source>. <year>2018</year>;<volume>8</volume>(<issue>7</issue>):<fpage>1869</fpage>&#x02010;<lpage>1878</lpage>.<pub-id pub-id-type="pmid">29556361</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0182"><label>182</label><mixed-citation publication-type="journal" id="mco2454-cit-0182">
<string-name>
<surname>Mentkowski</surname>
<given-names>KI</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>JK</given-names>
</string-name>. <article-title>Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo</article-title>. <source>Sci Rep</source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<elocation-id>10041</elocation-id>.<pub-id pub-id-type="pmid">31296886</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0183"><label>183</label><mixed-citation publication-type="journal" id="mco2454-cit-0183">
<string-name>
<surname>Mao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>YD</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>RL</given-names>
</string-name>, et&#x000a0;al. <article-title>Heart&#x02010;targeting exosomes from human cardiosphere&#x02010;derived cells improve the therapeutic effect on cardiac hypertrophy</article-title>. <source>J Nanobiotechnol</source>. <year>2022</year>;<volume>20</volume>(<issue>1</issue>):<fpage>435</fpage>.</mixed-citation></ref><ref id="mco2454-bib-0184"><label>184</label><mixed-citation publication-type="journal" id="mco2454-cit-0184">
<string-name>
<surname>Yao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Self&#x02010;assembly of stem cell membrane&#x02010;camouflaged nanocomplex for microRNA&#x02010;mediated repair of myocardial infarction injury</article-title>. <source>Biomaterials</source>. <year>2020</year>;<volume>257</volume>:<elocation-id>120256</elocation-id>.<pub-id pub-id-type="pmid">32736263</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0185"><label>185</label><mixed-citation publication-type="journal" id="mco2454-cit-0185">
<string-name>
<surname>Kang</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mun</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Yun</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Joung</surname>
<given-names>B</given-names>
</string-name>. <article-title>Co&#x02010;delivery of curcumin and miRNA&#x02010;144&#x02010;3p using heart&#x02010;targeted extracellular vesicles enhances the therapeutic efficacy for myocardial infarction</article-title>. <source>J Control Release</source>. <year>2021</year>;<volume>331</volume>:<fpage>62</fpage>&#x02010;<lpage>73</lpage>.<pub-id pub-id-type="pmid">33460670</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0186"><label>186</label><mixed-citation publication-type="journal" id="mco2454-cit-0186">
<string-name>
<surname>Liu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Nakanishi</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Cardiac recovery via extended cell&#x02010;free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells</article-title>. <source>Nat Biomed Eng</source>. <year>2018</year>;<volume>2</volume>(<issue>5</issue>):<fpage>293</fpage>&#x02010;<lpage>303</lpage>.<pub-id pub-id-type="pmid">30271672</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0187"><label>187</label><mixed-citation publication-type="journal" id="mco2454-cit-0187">
<string-name>
<surname>Chen</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Zaman</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Sustained release of endothelial progenitor cell&#x02010;derived extracellular vesicles from shear&#x02010;thinning hydrogels improves angiogenesis and promotes function after myocardial infarction</article-title>. <source>Cardiovasc Res</source>. <year>2018</year>;<volume>114</volume>(<issue>7</issue>):<fpage>1029</fpage>&#x02010;<lpage>1040</lpage>.<pub-id pub-id-type="pmid">29566124</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0188"><label>188</label><mixed-citation publication-type="journal" id="mco2454-cit-0188">
<string-name>
<surname>Zou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Restoring cardiac functions after myocardial infarction&#x02013;ischemia/reperfusion via an exosome anchoring conductive hydrogel</article-title>. <source>ACS Appl Mater Interfaces</source>. <year>2021</year>;<volume>13</volume>(<issue>48</issue>):<fpage>56892</fpage>&#x02010;<lpage>56908</lpage>.<pub-id pub-id-type="pmid">34823355</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0189"><label>189</label><mixed-citation publication-type="journal" id="mco2454-cit-0189">
<string-name>
<surname>Yuan</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>CX</given-names>
</string-name>, et&#x000a0;al. <article-title>Microneedle patch loaded with exosomes containing microRNA&#x02010;29b prevents cardiac fibrosis after myocardial infarction</article-title>. <source>Adv Healthcare Mater</source>. <year>2023</year>;<volume>12</volume>(<issue>13</issue>):<elocation-id>e2202959</elocation-id>.</mixed-citation></ref><ref id="mco2454-bib-0190"><label>190</label><mixed-citation publication-type="journal" id="mco2454-cit-0190">
<string-name>
<surname>Monguio&#x02010;Tortajada</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Prat&#x02010;Vidal</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Martinez&#x02010;Falguera</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Acellular cardiac scaffolds enriched with MSC&#x02010;derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine model</article-title>. <source>Theranostics</source>. <year>2022</year>;<volume>12</volume>(<issue>10</issue>):<fpage>4656</fpage>&#x02010;<lpage>4670</lpage>.<pub-id pub-id-type="pmid">35832072</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0191"><label>191</label><mixed-citation publication-type="journal" id="mco2454-cit-0191">
<string-name>
<surname>Cheng</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>A pH/H(2) O(2) /MMP9 time&#x02010;response gel system with Sparc(high) tregs derived extracellular vesicles promote recovery after acute myocardial infarction</article-title>. <source>Adv Healthc Mater</source>. <year>2022</year>;<volume>11</volume>(<issue>22</issue>):<elocation-id>e2200971</elocation-id>.<pub-id pub-id-type="pmid">36056927</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0192"><label>192</label><mixed-citation publication-type="journal" id="mco2454-cit-0192">
<string-name>
<surname>Xu</surname>
<given-names>JX</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>JX</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>YD</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>YF</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>GX</given-names>
</string-name>. <article-title>Recent advances of natural and bioengineered extracellular vesicles and their application in vascular regeneration</article-title>. <source>Regen Biomater</source>. <year>2022</year>;<volume>9</volume>:<elocation-id>rbac064</elocation-id>.<pub-id pub-id-type="pmid">36176713</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0193"><label>193</label><mixed-citation publication-type="journal" id="mco2454-cit-0193">
<string-name>
<surname>Garikipati</surname>
<given-names>VNS</given-names>
</string-name>, <string-name>
<surname>Shoja&#x02010;Taheri</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Kishore</surname>
<given-names>R</given-names>
</string-name>. <article-title>Extracellular vesicles and the application of system biology and computational modeling in cardiac repair</article-title>. <source>Circ Res</source>. <year>2018</year>;<volume>123</volume>(<issue>2</issue>):<fpage>188</fpage>&#x02010;<lpage>204</lpage>.<pub-id pub-id-type="pmid">29976687</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0194"><label>194</label><mixed-citation publication-type="journal" id="mco2454-cit-0194">
<string-name>
<surname>Sluijter</surname>
<given-names>JPG</given-names>
</string-name>, <string-name>
<surname>Davidson</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Boulanger</surname>
<given-names>CM</given-names>
</string-name>, et&#x000a0;al. <article-title>Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position paper from the working group on cellular biology of the heart of the European Society of Cardiology</article-title>. <source>Cardiovasc Res</source>. <year>2018</year>;<volume>114</volume>(<issue>1</issue>):<fpage>19</fpage>&#x02010;<lpage>34</lpage>.<pub-id pub-id-type="pmid">29106545</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0195"><label>195</label><mixed-citation publication-type="journal" id="mco2454-cit-0195">
<string-name>
<surname>Wiklander</surname>
<given-names>OPB</given-names>
</string-name>, <string-name>
<surname>Brennan</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Lotvall</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Breakefield</surname>
<given-names>XO</given-names>
</string-name>, <string-name>
<surname>El Andaloussi</surname>
<given-names>S</given-names>
</string-name>. <article-title>Advances in therapeutic applications of extracellular vesicles</article-title>. <source>Sci Transl Med</source>. <year>2019</year>;<volume>11</volume>(<issue>492</issue>):<elocation-id>eaav8521</elocation-id>.<pub-id pub-id-type="pmid">31092696</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0196"><label>196</label><mixed-citation publication-type="journal" id="mco2454-cit-0196">
<string-name>
<surname>Martins&#x02010;Marques</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hausenloy</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Sluijter</surname>
<given-names>JPG</given-names>
</string-name>, <string-name>
<surname>Leybaert</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Girao</surname>
<given-names>H</given-names>
</string-name>. <article-title>Intercellular communication in the heart: therapeutic opportunities for cardiac ischemia</article-title>. <source>Trends Mol Med</source>. <year>2021</year>;<volume>27</volume>(<issue>3</issue>):<fpage>248</fpage>&#x02010;<lpage>262</lpage>.<pub-id pub-id-type="pmid">33139169</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0197"><label>197</label><mixed-citation publication-type="journal" id="mco2454-cit-0197">
<string-name>
<surname>Kooijmans</surname>
<given-names>SAA</given-names>
</string-name>, <string-name>
<surname>Schiffelers</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Zarovni</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Vago</surname>
<given-names>R</given-names>
</string-name>. <article-title>Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: new nanotools for cancer treatment</article-title>. <source>Pharmacol Res</source>. <year>2016</year>;<volume>111</volume>:<fpage>487</fpage>&#x02010;<lpage>500</lpage>.<pub-id pub-id-type="pmid">27394168</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0198"><label>198</label><mixed-citation publication-type="journal" id="mco2454-cit-0198">
<string-name>
<surname>Guo</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>LL</given-names>
</string-name>, et&#x000a0;al. <article-title>Small extracellular vesicles&#x02010;based cell&#x02010;free strategies for therapy</article-title>. <source>Medcomm</source>. <year>2021</year>;<volume>2</volume>(<issue>1</issue>):<fpage>17</fpage>&#x02010;<lpage>26</lpage>.<pub-id pub-id-type="pmid">34766134</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0199"><label>199</label><mixed-citation publication-type="journal" id="mco2454-cit-0199">
<string-name>
<surname>Chang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>P</given-names>
</string-name>. <article-title>Bone marrow mesenchymal stromal cell&#x02010;derived small extracellular vesicles: a novel therapeutic agent in ischemic heart diseases</article-title>. <source>Front Pharmacol</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>1098634</elocation-id>.<pub-id pub-id-type="pmid">36686710</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0200"><label>200</label><mixed-citation publication-type="journal" id="mco2454-cit-0200">
<string-name>
<surname>Lazana</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Anagnostopoulos</surname>
<given-names>C</given-names>
</string-name>. <article-title>A novel, cell&#x02010;free therapy to enter our hearts: the potential role of small EVs in prevention and treatment of CVD</article-title>. <source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>(<issue>7</issue>):<fpage>3662</fpage>.<pub-id pub-id-type="pmid">35409022</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0201"><label>201</label><mixed-citation publication-type="journal" id="mco2454-cit-0201">
<string-name>
<surname>Davidson</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Boulanger</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Aikawa</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles</article-title>. <source>Cardiovasc Res</source>. <year>2023</year>;<volume>119</volume>(<issue>1</issue>):<fpage>45</fpage>&#x02010;<lpage>63</lpage>.<pub-id pub-id-type="pmid">35325061</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0202"><label>202</label><mixed-citation publication-type="journal" id="mco2454-cit-0202">
<string-name>
<surname>De Wever</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Hendrix</surname>
<given-names>A</given-names>
</string-name>. <article-title>A supporting ecosystem to mature extracellular vesicles into clinical application</article-title>. <source>EMBO J</source>. <year>2019</year>;<volume>38</volume>(<issue>9</issue>):<elocation-id>e101412</elocation-id>.<pub-id pub-id-type="pmid">30975688</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0203"><label>203</label><mixed-citation publication-type="journal" id="mco2454-cit-0203">
<string-name>
<surname>Zhang</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>XL</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>JC</given-names>
</string-name>, et&#x000a0;al. <article-title>Small but significant: insights and new perspectives of exosomes in cardiovascular disease</article-title>. <source>J Cell Mol Med</source>. <year>2020</year>;<volume>24</volume>(<issue>15</issue>):<fpage>8291</fpage>&#x02010;<lpage>8303</lpage>.<pub-id pub-id-type="pmid">32578938</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0204"><label>204</label><mixed-citation publication-type="journal" id="mco2454-cit-0204">
<string-name>
<surname>Li</surname>
<given-names>QY</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>ZY</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>QZ</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeted immunomodulation therapy for cardiac repair by platelet membrane engineering extracellular vesicles via hitching peripheral monocytes</article-title>. <source>Biomaterials</source>. <year>2022</year>;<volume>284</volume>:<elocation-id>121529</elocation-id>.<pub-id pub-id-type="pmid">35447403</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0205"><label>205</label><mixed-citation publication-type="journal" id="mco2454-cit-0205">
<string-name>
<surname>Rayamajhi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>TDT</given-names>
</string-name>, <string-name>
<surname>Marasini</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Aryal</surname>
<given-names>S</given-names>
</string-name>. <article-title>Macrophage&#x02010;derived exosome&#x02010;mimetic hybrid vesicles for tumor targeted drug delivery</article-title>. <source>Acta Biomater</source>. <year>2019</year>;<volume>94</volume>:<fpage>482</fpage>&#x02010;<lpage>494</lpage>.<pub-id pub-id-type="pmid">31129363</pub-id>
</mixed-citation></ref><ref id="mco2454-bib-0206"><label>206</label><mixed-citation publication-type="journal" id="mco2454-cit-0206">
<string-name>
<surname>van der Meel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Fens</surname>
<given-names>MHAM</given-names>
</string-name>, <string-name>
<surname>Vader</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>van Solinge</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Eniola&#x02010;Adefeso</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Schiffelers</surname>
<given-names>RM</given-names>
</string-name>. <article-title>Extracellular vesicles as drug delivery systems: lessons from the liposome field</article-title>. <source>J Control Release</source>. <year>2014</year>;<volume>195</volume>:<fpage>72</fpage>&#x02010;<lpage>85</lpage>.<pub-id pub-id-type="pmid">25094032</pub-id>
</mixed-citation></ref></ref-list></back></article>
